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CHAPTER 1 
INTRODUCTION 
Ionizing Radiation 
Ionizing radiation is a form of energy that can displace electrons from atoms or 
molecules, producing ions that can disrupt biological processes and cause damage 
such as single and double strand DNA breaks. DNA double strand breaks are especially 
problematic to cells and can lead to cell death, and incorrect DNA repair can result in 
chromosome aberrations which increase the risk of cancer. Sources of exposure to 
ionizing radiation include radon, diagnostic procedures such as X-rays, CT scans and 
mammograms, radiation therapy for cancer treatment, occupational exposures, and 
radiological accidents.  
There are different kinds of ionizing radiation based on the type of particle 
emitted and the energy and charge of that particle. Directly ionizing radiation can be of 
two types, alpha particles which are nuclei of helium atoms and beta particles which are 
electrons. Both carry a charge and can therefore directly interact with atoms in 
macromolecules. Alpha particles are emitted by the decay of large radioactive nuclei of 
heavy atoms such as uranium and radon. Indirectly ionizing radiation includes neutrons, 
gamma rays and X-rays. Neutrons are non-charged particles and when they collide with 
atomic nuclei they create ions which will in turn cause damage to other molecules. 
Gamma rays and X-rays are electromagnetic waves of photons emitted either from the 
nucleus of an atom or from the outer electron shell, respectively. Both gamma rays and 
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X-rays can ionize atoms through the photoelectric effect by ejecting an electron from an 
atom they encounter, which in turn will cause damage to other nearby molecules.  
 
Radiation Exposures and Associated Risk Factors 
Despite the elevated cancer risks of ionizing radiation exposure, it can be very 
helpful for diagnostic and therapeutic purposes. Exposure to medical radiation has been 
rapidly increasing in developed countries over the past 10 years (Shah et al., 2012) and 
will likely continue to do so. Procedures such as CT scans, radiographs, X-rays, 
mammograms and fluoroscopy are routine yet very important components of modern 
medical care. While these procedures use very low doses of radiation, cumulative 
exposures over time can significantly increase the risk of developing cancer. Age at 
exposure is an important factor in assessing effects of radiation because it is well known 
that children experience increased cancer risks after exposure compared to adults 
(Kleinerman, 2006; Sadetzki and Mandelzweig, 2009; Stephan et al., 2007). Cancer 
risks are a subsequent consequence of radiation induced DNA damage, yet little is 
known about the basic cellular radiation susceptibility of cells from children compared to 
cells from adults. The benefits of medical diagnostic procedures are generally believed 
to outweigh the risks, but those risks are still important to consider and understand.  
Chronic low level exposure in the workplace (Sigurdson et al., 2008a; Yong et al., 
2009) and acute high dose exposures from nuclear incidents (Fushiki, 2013; Pierce and 
Mendelsohn, 1999) are other types of radiation exposures experienced by groups of 
people. Understanding the effects of ionizing radiation on humans and its implications 
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for health are important because while radiation can be a powerful tool, its use requires 
care and diligence to avoid adverse consequences. 
 
Structural Chromosome Aberrations 
Structural chromosome aberrations are a highly relevant biological endpoint 
because they are both a biomarker of exposure and a biomarker of effect. Structural 
aberration frequencies are known to be closely associated with cancer formation and to 
have some predictive ability for determining cancer risks (Bonassi et al., 2008; Bonassi 
et al., 2004; Hagmar et al., 1994; Hagmar et al., 2004). Nearly all cancer cells contain 
some form of chromosomal rearrangements (Frohling and Dohner, 2008; Gasparini et 
al., 2007), some of which have been characterized at the molecular level (Edwards, 
2009; Kaye, 2009). 
Translocations are one of the aberration types often used as a biomarker for 
detection of exposures from genotoxic agents and ionizing radiation (Tucker, 2002, 
2008b). Translocations are the most stable aberration type because cells with these 
exchanges generally do not undergo much negative selection pressure during mitosis. 
For this reason translocations accumulate with exposures that are chronic (Tucker et 
al., 1997), or highly fractionated (Spruill et al., 1996), and they can persist for years in 
an individual. Translocations are ideal for use in radiation biodosimetry where acute as 
well as chronic exposures to individuals (Tucker and Luckinbill, 2011) and populations 
(Sigurdson et al., 2008a; Yong et al., 2009) can be detected. Baseline translocations in 
unexposed individuals increase steadily with age (Sigurdson et al., 2008b). 
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Figure 1.1 shows the mechanism of formation for reciprocal translocations, 
dicentrics, fragments, rings and insertions. Each of these aberration types is the result 
of multiple double strand DNA breaks induced in one or more chromosomes that 
subsequently are mis-repaired. Exchanges that are even more complex are possible, 
and their number and complexity will depend on how many double strand DNA breaks 
are induced in a cell and how they are mis-repaired (Natarajan and Boei, 2003). Figure 
1.2 shows an example of a normal metaphase cell as well as cells with different types of 
aberrations that are commonly seen following radiation exposure.  
  
5 
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b) 
 
 
c) 
 
 
Figure 1.1 Mechanism of structural aberrations formation. a) Two breaks in two 
nonhomologous chromosomes can result in one of three outcomes: restoration of the 
original chromosomes, or the formation of a reciprocal translocation by an exchange of 
fragments, or the formation of a dicentric plus fragment when the two centric pieces and 
the two acentric pieces join together as shown. b) Two breaks in one chromosome can 
result in the formation of a ring and a fragment. c) Three breaks in two nonhomologous 
chromosomes can result in an insertion.  
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c) 
 
 
d) 
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e) 
 
 
f) 
 
Figure 1.2 Examples of cells in metaphase labeled with FISH whole chromosome 
paints and counterstained with DAPI showing structural chromosome aberrations. a) 
Normal cell in metaphase with chromosomes 1, 2 and 4 painted red and chromosomes 
3, 5 and 6 labeled simultaneously in green; all other chromosomes are counterstained 
with DAPI (blue). b) Reciprocal translocation (arrows) between a red and a green 
chromosome. c) Dicentric and an acentric fragment with a color junction (arrows). d) 
Insertion of a red segment into a green chromosome (arrows). e) Centric ring 
chromosome (thick arrow) and an acentric ring (thin arrow). f) Complex damage in a cell 
with at least 11 different color junctions (arrows). Several other types of structural 
aberrations are also present in panels (d) and (e) which are not marked. 
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There are many ways to visualize and count chromosome aberrations. Giemsa 
stained unbanded chromosomes (Mateuca et al., 2006) is a classic assay that allows 
detection of unstable events such as dicentrics, fragments and rings. It is inexpensive 
but compared to some other methods, scoring cells stained in this manner is time 
consuming and somewhat challenging. A major disadvantage is that stable 
rearrangements such as translocations and insertions cannot easily be detected. 
Giemsa banding (Bayani and Squire, 2004), with or without karyotyping, is a very 
thorough way to detect stable and unstable events in every chromosome in a cell. 
However analysis of G-banded cells is very time consuming and technically challenging, 
and is better suited when only small numbers of cells need to be analyzed. A more 
current technique is multicolor banding (mBAND) which produces bands in an array of 
colors, enabling the analysis of intra-chromosomal exchanges (Hada et al., 2011). 
Spectral karyotyping (SKY) (Belaud-Rotureau et al., 2003; MacLeod and Drexler, 2013) 
and multicolor-FISH (mFISH) (Liehr et al., 2004) are techniques where each 
homologous chromosome pair is painted in a single unique color using fluorescent in 
situ hybridization (FISH) whole chromosome paints. SKY and mFISH permit 
visualization and detection of all inter-chromosomal exchanges in a cell. However, these 
methods are very expensive, and technically demanding and time consuming to 
perform, much like karyotyping. Their major strength lies in analyzing the composition of 
tumor cells. However, for radiation exposure assessments, scoring a sufficient number 
of cells with banded chromosomes, SKY, or mFISH can be problematic because of the 
time required for analysis. At high doses of radiation an additional problem arises with 
these assays because the large number of aberrations makes the analyses even 
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slower. For these reasons, a different type of assay is needed in studies where large 
numbers of cells must be scored quickly and efficiently, particularly where obtaining 
sufficient statistical power is a concern.  
An approach that solves the twin problems of labor intensiveness and high cost 
involves FISH whole chromosome painting where the 6 largest chromosome pairs are 
painted in 2 contrasting colors (Tucker, 2010b). This method is advantageous because 
it enables large numbers of cells to be scored relatively quickly and easily, making it 
possible to collect data from many events in order to have enough statistical power to 
detect biologically relevant differences in response to radiation. Training people to be 
accurate slide readers is usually easy, and once trained, they can screen many cells 
quickly. Another advantage is that this method allows detection of both stable and 
unstable events such as translocations, dicentrics, fragments, rings and insertions. 
However, only exchanges between genetic material labeled in different colors can be 
seen, therefore only a portion of all exchanges can be quantified. To compensate for 
this issue, more metaphase cells can be scored. 
 
Cytokinesis Block Micronucleus Assay 
 Another cytogenetic method used to assess chromosome damage is the 
cytokinesis block micronucleus assay (CBMN) (Fenech and Morley, 1985), which has 
become extensively used for evaluating genotoxic exposures in mammalian cells 
(Bonassi et al., 2007; Mateuca et al., 2006). Micronuclei are now a well-accepted 
cytogenetic biomarker of exposure and effect (Bonassi et al., 2005; Garcia-Sagredo, 
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2008; Vral et al., 2011). DNA damage is visualized and measured simply by counting 
the number of micronuclei (MN) in binucleated cells. Any one micronucleus can contain 
whole chromosome(s) as the result of a non-disjunction event, and / or acentric 
fragment(s) that did not segregate to one of the daughter nuclei (Eastmond and Tucker, 
1989). As cells complete mitosis, cytokinesis is blocked by the addition of cytochalasin 
B and all the products of mitosis are retained in the cell membrane; any chromosomes 
or fragments that were not successfully segregated to either nucleus are visualized as 
MN. This method is inexpensive, it is easy to train personnel for scoring, and large 
numbers of cells can be analyzed very quickly. Figure 1.3 illustrates examples of 
binucleated cells with different numbers of micronuclei. 
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a) 
 
b) 
 
c)
 
d) 
 
Figure 1.3 Binucleated cells with varying numbers of micronuclei. a) no micronuclei, 
i.e., a normal cell; b) one micronucleus; c) 3 micronuclei; d) 7 micronuclei. Arrows 
indicate individual micronuclei. 
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Repair of Ionizing Radiation Induced DNA Damage  
 Maintaining an intact and error free genome throughout the life of a cell is 
important for avoiding cancer. Mutations in the DNA can lead to cell death, loss of cell 
cycle control and uncontrollable growth indicative of cancer. To protect themselves 
against these undesirable events, mammalian cells have evolved a complex and 
diverse mechanism to oversee the integrity and repair of its genome. Double strand 
DNA breaks (DSBs) can wreak havoc on genomes by promoting the loss of genetic 
material through degradation of broken ends by exonucleases, by failing to replicate the 
broken ends faithfully, or by the loss of DNA fragments during mitosis. To avoid these 
dangers, DSBs are quickly repaired via two major pathways of non-homologous end 
joining (NHEJ) and homologous recombination repair (HRR). NHEJ is the major 
pathway to repair ionizing radiation-induced DSBs; HRR also plays a smaller role in 
DSB repair mainly in S and G2 phases of the cell cycle. The repair machinery does not 
recognize which broken end belongs to which chromosome so there is a significant 
chance that a cell with two double strand breaks will incorrectly repair the loose ends 
and end up with a chromosome rearrangement. A detailed account of DNA repair is 
described in a recent comprehensive review (Thompson, 2012). 
 
Uranium, Depleted Uranium and Heavy Metal Toxicity 
 Many heavy metals are known to be human carcinogens (Hayes, 1997; Jarup, 
2003) and clastogens (Vainio and Sorsa, 1981) that have been linked to cancer 
formation as a result of chronic exposures in the workplace. Uranium is a naturally 
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occurring, extremely dense, heavy metal found in the soil and seawater that is mined 
and extracted for use in military as well as civilian applications. It is weakly radioactive 
due to the unstable nature of its isotopes 234U, 235U and 238U, which emit alpha particles 
upon decay. The 235U isotope has fissile properties and can maintain a nuclear chain 
reaction to generate heat for production of electricity and can be used to generate 
nuclear explosions. Natural Uranium must be enriched in the 235U isotope before it can 
be used as nuclear fuel; the byproduct of this process is Depleted Uranium (DU) which 
has less 235U and more 234U and 238U than natural Uranium. DU is much more stable 
than natural U and has a very low probability of fission. DU is most commonly used by 
the military in the manufacture of munitions and tank armor plating. However, whether 
DU exposure has long term consequences for human health has been debated (Bleise 
et al., 2003; Briner, 2010; Sztajnkrycer and Otten, 2004). Many studies have shown 
carcinogenic effects of DU in cell lines and animal models (Berradi et al., 2008; Darolles 
et al., 2010; Hao et al., 2009, 2012; LaCerte et al., 2010; Shaki et al., 2012; Xie et al., 
2010) but there is little evidence of adverse human health effects (Bakhmutsky et al., 
2011; Squibb et al., 2012).  
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Future Directions 
a) Long-term Depleted Uranium Exposure on Gulf War Veterans 
Chapters 2 and 3 describe the long term genotoxic effects of Depleted Uranium 
exposure through inhalation of DU dust and wound contamination on Gulf War 1 
Veterans as measured by MN formation and FISH whole chromosome painting. Even 
though no association was found between DU exposure and the cytogenetic 
biomarkers, for the 80 Veterans enrolled in this health surveillance program it will be 
important to monitor them for possible long term health effects for the rest of their lives. 
Since some of these Veterans are as young as 40 years of age, most likely another 40 
years of monitoring would be necessary, since it could be detrimental to miss any 
possible long term health effects related to DU. Of greatest concern are the individuals 
with embedded DU fragments because they continue to excrete high levels of Uranium 
in their urine, and because some individuals show tissue changes around the fragment 
site. These tissue changes may present future problems such as pain and discomfort, 
irritation and possibly benign or even cancerous growths.  
b) Susceptibility to Ionizing Radiation Increases with Age in Humans  
 Chapter 4 presents important findings that newborns are more susceptible to 
radiation than adults, and that adults show no difference in susceptibility as they age. To 
better understand how and when this elevated susceptibility of newborns declines with 
age it would be helpful to assess children and young adults ages 0 – 21 for their 
responses to radiation. Fetal susceptibility is another interesting question that could be 
explored in an animal model such as rats. We did not measure cell growth kinetics and 
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cell concentrations during the 48 hr culture period, and gathering such data in a future 
experiment may help elucidate an insight into this difference in susceptibility.  
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CHAPTER 2 
 This chapter has been previously published in the journal “Mutation Research: 
Genetic Toxicology and Molecular Mutagenesis”: 
Bakhmutsky M.V., Oliver M.S., McDiarmid M.A., Squibb K.S., Tucker J.D., 2010. Long 
term depleted uranium exposure in Gulf War I Veterans does not cause elevated 
numbers of micronuclei in peripheral blood lymphocytes, Mutation Research 720 (2011) 
53–57 
Long Term Depleted Uranium Exposure In Gulf War I Veterans Does Not Cause 
Elevated Numbers Of Micronuclei In Peripheral Blood Lymphocytes 
 
INTRODUCTION 
Depleted uranium (DU) is a heavy metal that is both radioactive and hazardous 
due to its chemical properties. Natural U is composed of three U isotopes (U 234, U235 
and U238). DU is a by-product of the U enrichment process that natural uranium 
undergoes in order to extract the U235 isotope for use in nuclear weapons and nuclear 
fuel production. Thus, DU has a lower U235/U238 ratio and is approximately 40% less 
radioactive than natural U. DU metal is used for military applications due to its high 
density, high pyrophoricity, tensile strength that is similar to steel, high availability, and 
low cost. It is ideal for use in armor piercing munitions because it has self-sharpening 
properties upon impact allowing it to penetrate armor more effectively than other metals. 
DU dust is formed upon impact of the projectiles, which is one source of internal 
inhalation exposure to DU in the battlefield. The other military application of DU is for 
protective tank armor, which can increase inhalation and ingestion exposures to DU 
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dust if a munition pierces DU armor during battle (Parkhurst, 2005). Under normal 
conditions, occupants of tanks with DU armor are also exposed to increased amounts of 
DU-derived radiation. However, this additional radiation dose is very small and does not 
constitute a significant health risk (Bleise et al., 2003). The heavy metal toxicity of DU is 
generally considered to present a greater health hazard than its radioactivity. 
External exposure to DU does not present a significant health hazard, but 
internal exposure via dust particle inhalation and embedded DU fragments may lead to 
adverse health effects due to both chemical and radiological toxicity. In vitro studies in 
human cell lines treated with soluble DU compounds show increased transformation to 
tumorigenic phenotypes; several bacterial strains show increased mutagenic activity 
after DU exposure and animal models implanted with DU pellets developed local tumors 
(National_Research_Council, 2008). These results suggest that DU may increase the 
risk of cancer (Sztajnkrycer and Otten, 2004). However, in contrast to the animal and in 
vitro studies, humans exposed to high internal and external doses of DU do not appear 
to suffer measurable health effects (Dorsey et al., 2009; Marshall, 2008). For 18 years, 
the Department of Veterans Affairs (VA) has been monitoring the health of Gulf War I 
Veterans that were exposed to DU during friendly fire incidents. In addition to inhalation 
and ingestion exposures, about forty percent of this cohort sustained traumatic injury 
resulting in embedded fragments of DU being retained in soft tissue. During biennial 
visits to the Baltimore VA Medical Center, the Veterans are monitored for the 
concentration of DU in their urine, for clinical chemistry measures that assess organ 
system function with a focus on biomarkers of adverse effects on the renal and 
reproductive systems, and for hematological, neuroendocrine and bone metabolism 
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parameters. Additional tests have included measures of chromosomal aberrations and 
HPRT mutation frequency in blood lymphocytes. To date, no clinically significant DU-
related health effects have been observed, even in subjects with the highest urine 
uranium concentrations (McDiarmid et al., 2004; McDiarmid et al., 2009; McDiarmid et 
al., 2001a; McDiarmid et al., 2007; McDiarmid et al., 2006; McDiarmid et al., 2000; 
McDiarmid et al., 2001b; Squibb and McDiarmid, 2006).  
Enumeration of micronuclei (MN) in peripheral blood lymphocytes (PBLs) is a 
well-established cytogenetic method for detecting chromosome damage caused by 
radiation and chemical exposures in humans (Bonassi et al., 2001). Here we used the 
cytokinesis-blocked MN assay to measure the number of MN found in the PBLs of DU-
exposed Gulf War I Veterans enrolled in the VA monitoring program. The goal of this 
study was to determine whether DU exposure as measured by urine U concentration 
results leads to detectable levels of cytogenetic damage. The results indicate that 
chronic systemic exposure to DU in Gulf War I Veterans with embedded DU fragments 
does not result in elevated frequencies of MN in peripheral blood lymphocytes 
compared to the frequencies of MN in Veterans with normal U body burdens.  
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MATERIALS AND METHODS 
Recruitment of Subjects 
The number of micronuclei present in peripheral blood lymphocytes was 
measured in blood samples collected from 35 members of the Veteran Administration 
(VA)’s DU-exposed Gulf War I veteran cohort who participated in the 4-day medical 
surveillance visit at the Baltimore VA Medical Center (Baltimore, MD) between April and 
June, 2009. Although all 79 members of this cohort were invited to participate in this 
surveillance visit, only about half of the total cohort accepted the invitation due to 
personal, employment or military service schedule constraints. One participant was 
excluded from this examination of micronuclei because he had previously received 
Cobalt radiation therapy. Demographics for the group of 35 Veterans that were 
examined for micronuclei in blood lymphocytes are shown in Table 1. Approximately 
43% of the Veterans in this group had evidence of embedded fragments when 
examined by x-ray.  
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Table 1. Demographic characteristics of the DU follow-up program 2009 
medical surveillance visit participants 
 2009 Cohort (n=35) 
N % 
Gender (% males) 35 100 
Race   
     African American 12 34% 
     Asian American 1 3% 
     Caucasian 20 57% 
     Hispanic 2 6% 
Participants with embedded 
DU fragments  
15 43% 
Age * 43.62 + 5.35 
* Mean age at time of 2009 evaluation (+ standard deviation) 
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Blood Collection, Cell Culturing, Slide Preparation and Staining, and Micronuclei 
Analysis 
Blood was drawn using 6 mL green topped vacutainer tubes containing heparin. 
The tubes were kept on a tilt shaker at low speed until they were prepared for shipping 
(within 2 hr). The blood samples were shipped overnight from the Baltimore VA Medical 
Center to Wayne State University with ice packs to remain cold (approximately 4C). 
Samples were stored at 4C upon arrival for 1-2 hours before culturing. 
Lymphocytes were isolated by carefully layering 2 mL of blood diluted with 2 mL 
Hank’s Balanced Salt Solution (HBSS) over 3 mL Lymphocyte Separation Medium 
(Mediatech, Inc.), then centrifuged at 400 x g at room temperature for 30 minutes. The 
mononuclear cell layer was transferred to a new tube and mixed with 4 mL HBSS, then 
centrifuged for 10 minutes at 260 x g at room temperature. The cell pellet was washed 
twice with 4 mL HBSS and centrifuged for 10 minutes at 260 x g at room temperature. 
The pellet was then re-suspended in 1 mL RPMI 1640 medium (Hyclone), 
supplemented with 15% Fetal Bovine Serum (Atlanta Biologicals), penicillin–
streptomycin (100 units/mL penicillin G sodium, 100 g/mL streptomycin in 0.85% 
saline, Gibco), 0.02 mg/mL PHA (Gibco) and 2 mM L-glutamine (Gibco). A cell count of 
the 1 mL cell suspension was obtained and cultures were seeded at a concentration of 
approximately 500,000 cells/mL. Cells were incubated in a fully humidified incubator 
with 5% CO2 at 37C in T25 suspension culture flasks (Corning) for 44 hours, then 
treated with Cytochalasin B (Sigma–Aldrich) (6 g/mL final concentration) and cultured 
for an additional 28 hours for a total culture time of 72 hours. Cells were re-suspended 
in their culture medium with a transfer pipette to break up cell clumps. The cells were 
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then spun onto pre-cleaned microscope slides using a cytocentrifuge (Stat-Spin) for 4 
min at 1300 RPM. The slides were air dried and fixed in 100% methanol for 15 min, 
then dried and stored at room temperature until staining. Slides were stained with 10% 
Giemsa Solution in Sorenson’s buffer (67 mM Na2HPO4, 67 mM KH2PO4 pH 6.8) for 15 
minutes, rinsed briefly in distilled H20, air-dried and then mounted with Permount (Fisher 
Scientific) and a glass coverslip. 
All blood samples were coded prior to shipping to the cytogenetics laboratory. 
The code was not broken until all the slide scoring had been completed. A total of 2000 
binucleated cells were scored from each donor under a light microscope (Nikon Eclipse 
E200) by 2 trained individuals each of whom scored 1000 cells. Only intact, binucleated 
cells with clearly distinct nuclei were scored (Fenech et al., 2003); the number of 
micronuclei (MN) per sample as well as the number of cells with 0, 1, 2, 3, 4, and 5 or 
more MN were recorded. Binucleated cells containing nucleoplasmic bridges were 
excluded from scoring. The Nuclear Division Index (average number of nuclei per cell) 
was also determined for each sample. 
 
Urine Uranium Analysis 
 At each biennial health surveillance visit, twenty-four hour urine samples are 
collected from each subject and shipped to the Armed Forces Institute of Pathology, 
Department of Environmental Toxicologic Pathology (Washington, DC) for analysis of 
total uranium using a previously described inductively coupled plasma-dynamic reaction 
cell-mass spectrometer (ICP-DR-MS) method (Ejnik, 2005; McDiarmid et al., 2007). 
Urine U concentrations are standardized on the basis of urine creatinine concentrations 
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to obtain micrograms of U per gram of creatinine to account for urine dilution due to 
water intake and/or dehydration (Karpas, 1998; McDiarmid et al., 2000).  
 
Uranium Exposure Metric 
A mean urine U (uU) exposure metric for each participant in this study was 
calculated using all the uU concentrations obtained for a participant each time they had 
participated in a surveillance visit at the Baltimore VA between 1994 and 2007. This U 
exposure metric, labeled mean uU 2007, was used to determine whether a relationship 
exists between mean uU exposure over the past 18 years and the presence of 
micronuclei in blood lymphocytes.  
 
Statistical Analysis 
The Mann-Whitney U test was used to test for the significance of differences 
observed between High versus Low U exposed groups established based on each 
participant’s mean uU 2007 value. Historically, the Baltimore VA DU health surveillance 
program has used a cut-off value of 0.1 g U/g creatinine for dividing High from Low 
exposed individuals (McDiarmid et al., 2009). This cut-off point was chosen because it 
was between the 95% percentile reported by (National Health and Nutrition Examination 
Survey (NHANES), 2003) for creatinine-adjusted urine U concentrations in U.S. 
populations with normal exposure to natural U through their diet and drinking water 
(0.034 g/g creatinine) and 0.35 g/L, a value reported as a uU upper limit in 
populations living in areas where natural U is elevated in water and food (International 
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Commission on Radiologic Protection (ICRP), 1974). Differences were considered 
statistically significant when calculated p values were < 0.05.  
Data were also analyzed using regression analysis. Since micronuclei frequency 
is a discrete variable created by a count, Poisson or Negative Binomial probability 
distribution is indicated for multivariate analysis (Ceppi et al., 2010). Poisson distribution 
can be used when the mean equals the variance but the negative binomial is indicated 
when this assumption is violated (e.g., by over-dispersion). The use of the Poisson 
regression to estimate the association of micronuclei abnormality frequency with urine 
uranium adjusting for age, current smoking and x-ray exposure during the past year was 
examined using the statistical package STATA version 11 (StataCorp, College Station, 
Texas). Because of over-dispersion of the data, the results of the equivalent negative 
binomial distribution are reported. 
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RESULTS 
 A total of 35 Veterans were evaluated for the formation of MN as a function of 
their urine U concentrations. All subjects were adult males, ranging from 36 to 59 years 
of age. Table 2 shows the ages of each subject, the mean urine Uranium concentrations 
calculated for each individual (mean uU 2007) and the MN data obtained from each 
subject. Cells with 0, 1, 2, 3, 4, 5 and >5 MN were observed. 
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Table 2. Urine uranium concentrations and MN data by donor and group. 
Donor 
Code 
Urine 
[U] (µg 
U/g cre) 
Donor 
Age 
Number 
of Normal 
Cells 
Number of 
Cells with 
MN 
Mean MN 
per 1000 
cells 
Nuclear 
Division Index 
High exposure group (> 0.1 µg U/g cre) 
102 0.81 38.59 1948 52 38.0 1.31 
104 32.61 51.47 1976 24 12.5 1.28 
105 40.40 41.74 1967 33 18.0 1.48 
115 0.12 41.83 1967 33 18.5 1.72 
116 0.46 50.49 1963 37 21.5 1.34 
122 1.58 45.9 1978 22 14.0 1.39 
123 1.56 39.18 1975 25 14.0 1.74 
129 2.19 44.03 1980 20 12.0 1.46 
145 12.7 56.06 1947 53 32.5 1.15 
193 3.98 45.86 1937 63 42.0 1.47 
199 2.5 44.81 1971 29 18.0 1.66 
201 0.15 40.3 1983 17 12.0 1.62 
202 0.39 40.96 1980 20 11.5 1.85 
Mean 7.65 44.71 1967 32.92 20.35 1.50 
S.D. 13.32 5.24 14.59 14.59 10.42 0.21 
Low exposure group (< 0.1 µg U/g cre) 
101 0.064 41.78 1927 73 43.5 1.45 
110 0.007 42.49 1989 11 8.5 1.48 
119 0.005 48.84 1966 34 21.0 1.54 
126 0.016 38.54 1972 28 18.0 1.57 
130 0.010 40.37 1963 37 19.5 1.55 
134 0.005 42.66 1984 16 10.5 1.63 
143 0.027 42.6 1968 32 18.5 1.34 
174 0.011 36.73 1976 24 13.0 1.48 
176 0.004 52.49 1972 28 17.5 1.51 
179 0.011 41.69 1982 18 9.0 1.51 
183 0.005 59.83 1952 48 30.0 1.33 
186 0.003 41.74 1949 51 29.5 1.48 
187 0.002 39.49 1974 26 13.5 1.64 
188 0.008 41.71 1977 23 16.5 1.31 
190 0.015 44.33 1980 20 12.0 1.45 
194 0.011 49.58 1957 43 27.0 1.51 
200 0.009 43.85 1982 18 9.5 1.18 
204 0.004 38.87 1970 30 19.0 1.44 
205 0.006 38.55 1936 64 34.5 1.31 
207 0.017 38.19 1978 22 12.0 1.37 
210 0.002 42.13 1963 37 19.0 1.34 
212 0.009 38.62 1980 20 10.5 1.33 
Mean 0.011 42.96 1968 31.95 18.73 1.44 
S.D. 0.013 5.43 15.7 15.72 9.15 0.12 
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To examine the relationship between MN frequency and U body burden, the 
participants in this cohort were divided into two groups based on their mean uU2007 
exposure metric, with the Low group consisting of all individuals with mean urine U 
concentrations below 0.1 g U/g creatinine and the individuals in the High group having 
concentrations equal to or above 0.1 g/g creatinine. The value of 0.1 ug U/g creatinine 
was chosen as the cut-point between the high and low groups based on its close 
proximity to the 95th percentile upper limit value reported by NHANES (2003) for the 
concentration of natural U in urine the U.S. population (0.043 ug/g creatinine). Twenty-
two (22) samples were placed in the Low group with mean urine [U] ranging from 0.002 
g U/g creatinine to 0.064 g U/g creatinine while 13 samples in the High group ranged 
from 0.12 g U/g creatinine to 40.41 g U/g creatinine. The effect of a high U burden on 
two MN outcome measures, 1) the number of cells with MN, or 2) the total number of 
MN per 2000 cells, was determined by comparing the mean values for these two 
parameters in the Low versus High groups. The mean number of cells with MN was 
32.9 in the High group vs. 32.0 in the Low group; while the average number of MN/1000 
binucleated cells in the Low group was 18.7 versus 20.4 for the High group. Statistical 
analysis of the data using the Mann Whitney test of significant difference indicated that 
the means of the Low versus High groups were not significantly different at the 0.05 
level for either parameter.  
Because micronuclei results are discrete variables created by a count, a more 
acceptable analysis for examining continuous relationships between data is the Poisson 
or Negative Binomial analysis (Ceppi et al., 2010). No significant relationships were 
observed between the mean uU2007 exposure metric and MN frequency when mean 
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uU2007 was examined by itself (Figure 2.1) or when covariates (current smoking, x-rays 
in the past year and age) were included in the analysis (data not shown). The 
relationship between the number of cells with MN and age was also examined and is 
shown in Figure 2.2. There was no significant relationship between MN frequency and 
age when examined separately or when controlled for uU concentrations, smoking and 
x-rays in the past year (data not shown).  
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Figure 2.1 Relationship between micronuclei frequency (MN/1000 cells) and the natural 
log of urine uranium concentrations of Gulf War I Veterans exposed to DU. No 
significant relationship exists between urine U excretion and the frequency of 
micronuclei in blood lymphocytes. Members of the cohort were separated into Low 
versus High uU groups based on the mean of their past urine U concentrations (Low uU 
concentrations are < 0.1 μg U/g creatinine; High uU concentrations are > 0.1 μg U/g 
creatinine). 
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Figure 2.2 Relationship between micronuclei frequency (MN/1000 cells) and the age of 
each veteran at the time of sampling. No significant relationship exists between age and 
the frequency of micronuclei in blood lymphocytes. Members of the cohort were 
separated into Low versus High uU groups based on the mean of their past urine U 
concentrations (Low uU concentrations are < 0.1 μg U/g creatinine; High uU 
concentrations are > 0.1 μg U/g creatinine). 
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DISCUSSION 
 The results of our study show no difference in MN frequency in the high versus 
low urine U groups. This conclusion is consistent with other results from the DU 
surveillance program which has been monitoring the health of these Veterans since the 
1991 Gulf War. The surveillance program has not detected any significant health effects 
that can be attributed to DU exposure, even in those Veterans with DU shrapnel in their 
bodies (McDiarmid et al., 2009). Urine Uranium levels in most of the Veterans in the DU 
exposed cohort are similar to the general U.S. population and only remain elevated in 
Veterans with embedded DU fragments (Dorsey et al., 2009). In a previous assessment 
of this DU-exposed ‘friendly-fire’ cohort, a group of Gulf War I deployed, but non- DU-
exposed controls was evaluated (McDiarmid et al., 2000). The urine U distribution of the 
non-DU exposed Veterans was found to be similar to the cohort of Veterans that are 
DU-exposed but without embedded fragments; these values were also within the normal 
range for the U.S. population. Thus, using uU as a measure of U body burden, the low 
uU group within the friendly-fire cohort of DU exposed Veterans provides an appropriate 
comparison group for the Veterans with embedded DU fragments who have high uU 
concentrations. 
We hypothesized that Veterans with substantial numbers of DU fragments 
embedded in their bodies may have elevated MN frequencies due to the prolonged and 
constant systemic DU exposure they experience. DU causes radiation exposure 
because it is a radioactive metal which naturally emits alpha particles along with beta 
and gamma radiation during the decay process (Bleise et al., 2003). The alpha particles 
are high energy but have low penetrating power and they can be a potential internal 
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hazard when DU is inhaled, ingested or found in wounds. The beta and gamma 
radiation are generally external exposure hazards, however, the overall radioactivity of 
DU is very low (Sztajnkrycer and Otten, 2004). Existing experimental evidence also 
suggests that DU may be genotoxic based on its chemical characteristics (Coryell and 
Stearns, 2006; Hartsock et al., 2007; Stearns et al., 2005).  
These data do not support our original hypothesis that MN may be elevated in 
Veterans with a chronically elevated U body burden due to embedded DU fragment 
retention. A possible physical explanation for this finding is that the embedded 
fragments are not close enough to the blood supply to cause any visible damage to the 
passing lymphocytes, either by emission of poorly penetrating alpha particles or by 
chemical toxicity. If many DU fragments are located close to large blood vessels, it 
would be more likely that radiation or chemical toxicity effects could be seen in the 
lymphocytes. The cells in the tissue surrounding the shrapnel would suffer the most 
damage from DU, and these effects would diminish with distance from the metal. 
Detailed information about the size, locations, and number of fragments embedded in 
each individual is not available.  
Although no significant relationship between elevated MN and uU concentration 
was observed in this study, DU exposure may lead to small increases in micronucleus 
frequencies in some individuals but these increases are too low to be detectable. The 
effect of DU exposure could be masked by factors that are known to influence MN 
frequencies, such as age and cigarette smoking. MN frequencies are known to increase 
with age (Bonassi et al., 2001; Hando et al., 1994), yet we do not see an age effect 
present in our results, probably due to the relatively small sample size. Cigarette 
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smoking can also be a factor in heavy smokers. The Human MicroNucleus Project 
examined the effects of smoking on MN frequencies in multiple studies involving nearly 
6000 subjects. These analyses indicate that smokers do not have more MN than non-
smokers, and even show a small decrease in MN frequencies. However, heavy 
smokers (at least 30 cigarettes per day) do show increases which can only be observed 
in people who are not occupationally exposed to genotoxic agents (Bonassi et al., 
2003). We controlled for current smoking (yes/no) in our regression analysis, but did not 
have information on the number of cigarettes smoked per day for each individual.  
Exposure to ionizing radiation can also lead to increased MN frequencies, thus 
we controlled for past exposure to x-rays as reported by the Veterans. Many received 
multiple X-rays or other diagnostic procedures following their injuries, however 
controlling for number of x-rays in the past year did not alter the relationship between 
MN and mean uU concentrations.  
Only one other study has used micronuclei to evaluate individuals with 
environmental exposure to DU. Krunic et al. (Krunic et al., 2005) recruited individuals 
from areas of Bosnia and Herzegovina where DU munitions were used during the 
Balkan conflict. A control population was recruited from West Herzegovina which was 
not impacted by war activities. Results of this study showed a small increase in the MN 
frequency in the exposed group compared to controls. However, there was no control 
for exposure to other genotoxic chemicals, and DU exposure was not directly measured 
in individual subjects but was assumed based on the presence of DU in environmental 
matrices (Krunic et al., 2005). Other important differences also exist between their study 
design and the one we report here. Krunic et al. evaluated individuals thought to be 
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exposed to DU dust through direct contact and aerosol inhalation, but did not include 
subjects with embedded shrapnel. Their control group consisted of unexposed 
individuals while our Low group consisted of individuals with previous exposure to DU 
but low urine U concentrations.  
Depleted Uranium exposure can be external (skin contact) and internal 
(ingestion, inhalation and embedded fragments) and present both radiological and 
chemical hazards. However, the levels of exposure that occurred during the 1991 Gulf 
War did not lead to significant increases in body burdens above non-exposed 
populations (Bleise et al., 2003) except in the cases involving embedded DU fragments. 
This study concurs with others showing that the DU exposure that occurred in Gulf War 
I Veterans with embedded DU fragments does not appear to increase biomarkers of 
genotoxic damage despite an ongoing elevation of their U body burdens for over 18 
years.  
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CHAPTER 3 
Long Term Depleted Uranium Exposure In Gulf War Veterans Does Not Cause 
Increased Chromosome Aberrations In Peripheral Blood Lymphocytes Measured 
By Fish Whole Chromosome Painting 
INTRODUCTION 
Depleted Uranium (DU) is a chemically toxic heavy metal with weak radioactive 
properties that is used extensively by the military in the manufacture of munitions and 
armor. Its appeal for use in weapons is due to its high density, pyrophoricity, self-
sharpening properties, and low cost. Uranium is the heaviest naturally occurring 
element normally found in soil, rocks and water; it is composed primarily of three 
isotopes, 234U (0.005%), 235U (0.72%) and 238U (99.27%), that emit alpha particles and 
beta radiation upon decay. Natural uranium is processed to increase the concentration 
of the fissile isotope 235U for use in nuclear fuel and nuclear weapons. The enrichment 
process results in the production of uranium metal that is depleted in 235U and 234U, and 
consequently has 40% less of the alpha particle emission than natural uranium. During 
the 1991 Gulf War, DU munitions were used extensively in combat (Sztajnkrycer and 
Otten, 2004) and consequently some military personal and civilians were exposed to 
DU, with the highest exposures accrued to service members involved in DU friendly fire. 
Exposures involved inhalation of DU dust, skin contact, wound contamination from 
particulate aerosol and from shrapnel embedded in tissue of those who were wounded, 
and entry of DU into food and water sources. At that time there were widespread 
concerns that DU exposure may have health consequences such as organ damage, 
increased cancer incidence, radiation exposure, and birth defects.  
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The most common form of DU exposure is through inhalation of particles, which 
are absorbed in the lungs if they are soluble and pass into blood plasma before being 
distributed throughout the body (Bleise et al., 2003; Briner, 2010). DU is then deposited 
in the bone, kidneys and other soft tissues. Only about 10% of inhaled soluble DU is 
retained in the body. Two-thirds of that will be rapidly excreted in the urine and much of 
the rest will be excreted over time (Marshall, 2008). This type of exposure is more 
transient compared to individuals with embedded shrapnel fragments who experience 
higher body burdens and chronic exposures that have been observed to persist for at 
least two decades as measured by urine Uranium concentrations (Squibb et al., 2012).  
The toxicity and radioactivity of DU have raised questions about its possible 
genotoxic effects, specifically in individuals suffering chronic exposure from embedded 
fragments compared to subjects with inhalation-only exposures and normal urine 
Uranium levels. Accordingly, the Department of Veterans Affairs has been monitoring a 
cohort of Gulf War I Veterans exposed to DU in friendly fire incidents for almost 20 
years for possible health effects from long term DU exposure (McDiarmid et al., In 
press; Squibb et al., 2012). This cohort suffered inhalation exposures and some 
experienced wound contamination with dust and embedded DU fragments that cannot 
be easily removed. Urine Uranium levels have been measured for all attending 
participants at every biennial visit. Individuals with inhalation-only exposures have urine 
Uranium levels similar to unexposed individuals from the general population, while 
subjects with retained embedded shrapnel continue to excrete elevated levels of DU in 
their urine. The clinical assessment provided by the DU Follow-Up Program includes a 
detailed medical history, physical examination, clinical chemistry measures, renal and 
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lung function testing, skin patch tests, and genotoxicity assays. To date, several tests of 
mutagenicity and clastogenicity have been conducted in this cohort including sister 
chromatid exchange (SCE), micronuclei, chromosome aberrations, and mutant 
frequencies of HPRT and PIGA (Bakhmutsky et al., 2011; McDiarmid et al., 2011a). 
Early SCE results were inconsistent as they related to DU exposure and many other 
markers provided non-statistically significant results with the exception of a possible 
threshold effect observed for HPRT mutations in the highest urine Uranium exposure 
group (summarized in McDiarmid et al., 2009). Similarly, the DU Follow-Up Program 
has found no significant U-related health effects associated with DU exposure in this 
cohort (Bakhmutsky et al., 2011; Dorsey et al., 2009; McDiarmid et al., 2011b; Squibb et 
al., 2012).  
 However, analyses of chromosome translocations have not been performed in 
DU-exposed individuals. Translocations are a common and widely used biomarker for 
evaluating chronic and acute radiation exposures. Elevated translocation frequencies 
are a biomarker of effect that may indicate an increased risk of developing cancer. 
Translocations are an integrating biodosimeter, i.e. they provide a lifetime cumulative 
measure of the different types of clastogenic exposures a person has had. 
Translocations are the most persistent of all structural chromosome aberrations. Their 
relative stability over time allows them to persist for decades. A baseline translocation 
frequency for nearly 2000 unexposed controls is available for comparison with our DU 
exposed Veterans (Sigurdson et al., 2008b; Tucker and Luckinbill, 2011), which enables 
radiation dose estimates to be made on individuals for whom no pre-exposure 
translocation data are available (Tucker and Luckinbill, 2011).  
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The purpose of the work described here is to extend the ongoing surveillance 
effort by the DU Follow-Up Program by evaluating chromosome translocation 
frequencies using FISH whole chromosome painting. 
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MATERIALS AND METHODS 
Recruitment of Subjects, and Blood and Data Collection 
 For this study, blood samples were collected from 35 members of the Veteran 
Administration (VA)’s DU-exposed Gulf War I veteran cohort who participated in the 4-
day medical surveillance visit at the Baltimore VA Medical Center (Baltimore, MD) 
between April and June 2011. Although all 80 members of this cohort were invited to 
participate in this surveillance visit, only about half of the total cohort accepted the 
invitation due to personal, employment or military service schedule constraints. 
Approximately 31% of the Veterans in this group had evidence of embedded fragments 
when examined by plain film X-ray. Each subject provided data via a health 
questionnaire, which requested their lifetime exposure to X-rays, pack years smoked, 
and alcohol use. Each participant’s questionnaire was reviewed for completeness. The 
surveillance protocol used in this work was approved by the Baltimore VAMC’s and the 
University of Maryland School of Medicine’s IRB programs. Each participant completed 
an informed consent document.  
Blood was drawn from each participant using 6 mL Becton Dickinson Vacutainer 
Sodium Heparin tubes. The blood samples were shipped overnight from the Baltimore 
VA Medical Center to Wayne State University with ice packs to maintain the 
temperature at approximately 4C. Samples were stored at 4C upon arrival for 2 hours 
before culturing. 
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Cell Culturing, Slide Preparation and FISH Painting 
 Eight hundred L of blood was dispensed into 10 mL of RPMI 1640 medium 
(Hyclone), supplemented with 15% Fetal Bovine Serum (Atlanta Biologicals), penicillin–
streptomycin (100 units/mL penicillin G sodium, 100 g/mL streptomycin in 0.85% 
saline, Gibco), 2% phytohemagglutinin (Gibco) and 2 mM L-glutamine (Gibco) pre-
warmed to 37C. Cultures were incubated vertically in T25 suspension flasks with 
vented caps (CELLSTAR) in a humidified chamber with 5% CO2 at 37C for 48 hrs. 
Cultures were treated with KaryoMAX Colcemid solution (10 g/mL, Gibco) at a final 
concentration of 0.1 g/mL after 44 hours in culture to arrest cells in metaphase. After 
48 hours cells were gently re-suspended and decanted into 15 mL conical tubes and 
centrifuged at 1400 RPM for 5 min at room temperature; supernatant was aspirated with 
a Pasteur pipette. The cell pellets were gently resuspended in 8 mL 75 mM KCL 
solution pre-warmed to 37C and incubated for 30 minutes at 37C. Two mL of freshly 
prepared fixative (methanol:acetic acid 3:1 v/v) solution was added to each tube, mixed 
thoroughly and centrifuged at 1400 RPM for 5 minutes. The supernatant was aspirated 
and the cells were washed with 2 mL of fixative 3 more times. The pellet was 
resuspended in pure glacial acetic acid and cells were dropped onto cooled microscope 
slides pre-cleaned with 70% ethanol over a 70C water bath to obtain metaphase 
spreads.  
 Slides were aged overnight at room temperature then stored in N2 gas with a 
desiccant pack at -20C. Samples were brought back to room temperature and were 
hybridized with FISH Whole Chromosome Painting kits from Cambio or Applied Spectral 
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Imaging according to the manufacturers’ protocols. Chromosomes 1, 2, 4 were painted 
with a Cy3 labeled probe and chromosomes 3, 5, 6 probes were labeled with FITC. 
Slides were mounted with 50 L ProLong Gold antifade reagent with DAPI (Invitrogen) 
and a glass coverslip. The chromosome paints from both manufacturers were 
comparable in quality and signal strength.  
 
Cell Scoring 
 Samples were coded prior to their arrival at the cytogenetics laboratory at Wayne 
State University and the code was not broken until all the data were collected. A 
minimum of 1800 metaphase cells or 1000 cell equivalents (CE; 1 CE = 0.56 
metaphase cell) (Tucker, 2010b) were scored for each subject by trained observers 
using epifluorescent microscopes. Coordinates and digital photographs were taken for 
all abnormal cells, and every abnormal cell was double checked by an expert 
cytogeneticist to assure accuracy and consistency in the identification of chromosome 
aberrations.  
All abnormalities in each metaphase cell were recorded using the PAINT 
nomenclature system (Tucker et al., 1995). Aberrant chromosomes with 2 or more 
junctions are referred to here as multi-junction chromosomes. Examples of these 
aberrations include (CBAb), (Bca), (abc), (cBc), (Bcbab), r(Ac) and (AAc), where A, B 
and C are portions of chromosomes painted blue, red and green respectively, and 
capital letters indicate material with a centromere. While insertions fit this definition, they 
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were not included in the multi-junction count. Note that some of these junctions involved 
adjacent pieces painted in the same color. 
Urine Uranium Analyses 
At each biennial health surveillance visit, twenty-four hour urine samples were 
collected from each subject and shipped to the Joint Pathology Center (JPC) 
Biophysical Toxicology Laboratory (Joint Base Andrews Naval Air Facility, MD) 
(previously the Armed Forces Institute of Pathology’s Department of Environmental 
Toxicologic Pathology, Washington DC) for analysis of total uranium using a previously 
described inductively coupled plasma-dynamic reaction cell-mass spectrometer (ICP-
DR-MS) method (Ejnik et al., 2005; McDiarmid et al., 2007). Isotopic analysis was also 
conducted on each sample to determine the U235/U238 ratio (Gray et al., 2012). Urine 
total Uranium concentrations were standardized on the basis of urine creatinine 
concentrations to obtain micrograms of U per gram of creatinine to account for urine 
dilution due to water intake and/or dehydration (Karpas et al., 1998; McDiarmid et al., 
2000).  
 
Statistical Analyses 
Least squares regression analyses were performed to evaluate the effects of 
urine Uranium, age, lifetime X-rays, cigarette smoking (in pack-years) and alcohol use 
on the frequencies of cells with translocated chromosomes, dicentrics, acentric 
fragments, color junctions, and abnormal cells per 100 CEs. Although Poisson 
regression is often used when cytogenetic data are being evaluated, here this approach 
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was problematic because the data did not fit a Poisson distribution, even upon 
transformation. For this reason all regressions assumed a normal distribution, and two 
variables, urine Uranium and lifetime X-rays, were log10 transformed because this 
helped normalize their variances. The remaining variables were not transformed as this 
did not help normalize their variances.  
Each of the cytogenetic variables was evaluated as the frequency of cells per 
100 CEs with the given type of aberration, rather than by the frequency of each 
aberration type per 100 CEs. There is no difference in these two approaches unless 
some cells have more than one of the given aberration type. Because the doses 
observed in this study are very low, cells containing more than one aberration of a given 
type are rare. Translocations are the most commonly observed aberration type because 
they are stable and increase in frequency with age (Sigurdson et al., 2008b). The 
problem with translocations is that they arise in multiple ways and can appear as 1-
junction (“1-way”) events, 2-junction (“2-way”) exchanges, and exchanges that are 3-
way and 4 (or more)-way. The problems enumerating translocation frequencies for 
dosimetry have been described in detail (Tucker, 2008a, 2010a). The existence and 
prevalence of multi-way chromosome exchanges has been demonstrated with studies 
involving mFISH (Loucas et al., 2013). By evaluating the frequency of cells with 
translocations we have avoided problems associated with the manner in which 
translocations are enumerated (Tucker, 2008a, 2010a). For consistency, all the other 
aberration types evaluated here were also analyzed as the frequency of cells with the 
given type of event.  
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Cells with color junctions include all junctions found in chromosomes with 
apparently simple exchanges as well as in chromosomes with more than one junction, 
however, the data from the multi-junction chromosomes were not included in any of the 
other aberration types.  
All statistical analyses were performed using JMP software, version 6.0, SAS 
Institute Inc. 
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RESULTS 
 A total of 35 Gulf War I Veterans were evaluated for chromosome aberrations 
with FISH whole chromosome painting. Table 3 shows the demographics of the 
participants in the 2011 health surveillance visit. All were males, ranging in age from 39 
to 62 years of age. Eleven participants (31%) have embedded DU fragments and all but 
one has higher urine Uranium concentrations compared to donors who do not have 
fragments. Donor age at time of blood draw, lifetime X-ray exposure, cigarette smoking, 
alcohol binges and urine Uranium concentrations are listed for each subject in Table 4.  
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Table 3. Demographic characteristics of the DU follow-up 
program 2011 medical surveillance visit participants.  
  
2011 cohort 
(n=35) 
    n % 
Gender (% males) 35 100 
Race   
 African American 11 31 
 Asian American 1 3 
 Caucasian 21 60 
 Hispanic 2 6 
Participants with embedded DU 
fragments 
11 31 
Age* 45.94 +/- 5.51  
* Mean age at the time of 2011 evaluation (± standard 
deviation) 
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Table 4. Urine Uranium concentration, age, lifetime X-rays received, pack years smoked 
and alcohol use for 2011 DU Follow-up Program medical surveillance visit participants. 
Donor 
code 
Urine Uranium 
concentration (µg 
U/g creatinine) 
Donor 
age 
X rays 
lifetime 
Pack 
years 
Alcohol 
use 
9-102 0.3682 41 15 13.34 no 
9-104 39.9574 54 20 8.5 no 
9-105 9.0231 44 21 2.5 no 
9-110 0.0054 44 100 0 no 
9-115 0.1131 44 25 0 no 
9-116 0.0828 52 35 0 no 
9-119 0.0009 51 11 0 no 
9-120 0.0059 53 20 0 no 
9-121 0.2116 49 10 0 no 
9-122 1.2307 48 100 26.25 yes 
9-123 2.5329 41 20 0 no 
9-126 0.0066 40 100 16.5 yes 
9-129 1.4165 46 30 0 no 
9-130 0.0037 42 50 0 no 
9-145 11.0453 58 24 2 no 
9-174 0.0020 39 51 2.63 yes 
9-176 0.0045 55 25 8 yes 
9-179 0.0040 44 100 48.39 no 
9-182 0.0125 54 17 39.03 no 
9-183 0.0047 62 31 6.49 no 
9-186 0.0039 44 6 0 no 
9-187 0.0024 41 no data 0 no 
9-190 0.0058 46 5 0 no 
9-193 2.8308 48 20 0 no 
9-194 0.0036 52 75 13.71 no 
9-198 0.0031 46 60 0 no 
9-199 0.9826 47 3 7.94 no 
9-200 0.0034 46 20 0 no 
9-204 0.0028 41 10 0 no 
9-205 0.0011 41 15 6.66 no 
9-210 0.0030 44 5 7 yes 
9-212 0.0094 41 no data 17 yes 
9-219 0.0057 48 30 0 no 
9-220 0.0125 43 18 28.99 no 
9-221 0.0331 43 no data 0 no 
Mean 2.00 46.6 33.5 7.3  
S.D. 7.03 5.6 30.1 11.9   
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A minimum of 1800 metaphase cells per donor were analyzed for chromosome 
damage. The numbers of normal cells, abnormal cells, color junctions and aberrant 
chromosomes including translocations, dicentrics, acentric fragments, insertions, centric 
and acentric rings, and multi-junction chromosomes observed per donor, are shown in 
Table 5. A total of 479 translocated chromosomes and 55 dicentric chromosomes were 
observed in the 64,193 metaphase cells evaluated in these 35 subjects. Translocated 
chromosomes are the predominant aberration type seen in this study because they are 
more stable than all other types of aberrations. Insertions are thought to have similar 
stability but are much more rare; only 5 were observed here. All donors were checked 
for possible clones of abnormal cells (Johnson et al., 1999) but none were found. 
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Table 5. Number of metaphase cells scored and types of aberrant chromosomes 
observed in individual participants. 
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9-102 1815 1810 5 9 8 1 0 0 0 0 
9-104 1820 1805 15 24 20 2 4 0 0 1 
9-105 1805 1798 7 23 13 2 7 0 0 3 
9-110 2000 1994 6 8 7 1 2 0 0 0 
9-115 1804 1799 5 8 8 0 1 0 0 0 
9-116 1813 1801 12 26 22 2 1 0 0 1 
9-119 1800 1791 9 24 16 3 2 0 0 2 
9-120 1812 1800 12 21 16 2 2 1 0 0 
9-121 1804 1797 7 16 15 0 1 0 0 0 
9-122 1813 1796 17 30 27 1 4 0 0 0 
9-123 1806 1800 6 11 10 0 1 0 0 0 
9-126 1802 1789 13 20 14 2 5 1 0 0 
9-129 1817 1812 5 10 8 1 1 0 0 0 
9-130 1867 1852 15 30 23 2 3 0 0 1 
9-145 1814 1792 22 50 28 8 10 1 0 1 
9-174 1814 1809 5 35 8 1 8 1 0 7 
9-176 1817 1814 3 5 4 1 0 0 0 0 
9-179 1812 1800 12 22 18 2 2 0 0 0 
9-182 1808 1803 5 10 10 0 0 0 0 0 
9-183 1804 1790 14 22 18 2 3 0 0 0 
9-186 1809 1802 7 11 10 1 1 0 0 0 
9-187 2386 2380 6 12 10 2 0 0 0 0 
9-190 1807 1796 11 25 15 2 2 0 0 3 
9-193 1809 1803 6 9 9 0 1 0 0 0 
9-194 1809 1791 18 39 24 6 7 1 0 1 
9-198 1809 1802 7 14 14 0 1 0 0 0 
9-199 1807 1799 8 8 9 1 6 0 0 2 
9-200 1813 1805 8 11 10 0 1 0 0 0 
9-204 1805 1799 6 12 12 0 0 0 0 0 
9-205 1822 1814 8 13 12 1 0 0 0 0 
9-210 1814 1809 5 9 7 1 1 0 0 0 
9-212 1814 1803 11 15 15 0 3 0 0 0 
9-219 1807 1803 4 6 3 2 2 0 0 0 
9-220 1817 1800 17 30 26 2 4 0 0 0 
9-221 1818 1811 7 27 10 4 10 0 3 4 
Total 64,193  63,869  324 645 479 55 96 5 3 26 
Mean 1834 1825 9 18 14 2 3 0 0 1 
S.D. 101.72 102.42 4.69 10.53 6.52 1.69 2.81 0.36 0.51 1.50 
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Some cells contained chromosomes with multiple junctions that did not readily fit 
into any aberrant chromosome category. A total of 14 cells containing 26 multi-junction 
chromosomes were found in 11 different donors (Table 6). Uncommon aberrations such 
as centric and acentric two-color rings and a chromosome with 5 color junctions were 
observed. Six cells with 10 or more color junctions were found in four donors (Figure 
3.1). Two of these 6 cells had too many color junctions to count reliably and were 
excluded from further analyses, the other four cells were included in these analyses. 
These highly damaged cells did not show any association with urine Uranium 
concentration. Table 7 presents the number of cells with each type of chromosome 
aberration, and includes the aberrations from the 4 highly damaged cells in which color 
junctions could be reliably counted.  
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Table 6. Multi-junction chromosomes observed. 
Donor 
code 
# of cells 
with multi-
junction 
chromosome
s 
# of multi-
junction 
chromosome
s 
Multi-junction chromosomes* 
9-104 1 1 (Bca) 
9-105 1 3 (cBc), (ABc), (CaC) 
9-116 1 1 (AAc) 
9-119 2 2 (aCabC), (AAc) 
9-130 1 1 (CAb) 
9-145 1 1 (Bcbab) 
9-174 2 7 
(Acb), (abc), (BcA), (AbaCa), (CbA), (Acbcab), 
(CBAb) 
9-190 2 3 (aBa), (bAb), (Cba) 
9-194 1 1 (bCa) 
9-199 1 2 (AcB), (cAca) 
9-221 1 4 (Abc), (bAba), r(ab), r(Ac) 
Total 14 26   
* Where A, B and C chromosomes are labeled blue, red and green respectively. 
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Figure 3.1 Highly damaged cells, which could be termed rogue, each with more than 10 
color junctions found in this study. The donor number is indicated beneath each image. 
Multi-junction chromosomes found in cells a, c, d, and f were scored for aberrations, 
which are listed in Table 4. The aberrations from these four cells are included in the 
analyses reported here. Cells b and e were not included in these analyses because the 
types and numbers of their aberrations could not be reliably determined.  
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Table 7. Number of cells with each type of chromosome aberration. 
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9-102 5 4 1 0 0 0 0 0 
9-104 11 11 2 4 0 0 0 1 
9-105 6 6 1 1 0 0 2ᵃ 1 
9-110 5 4 1 2 0 0 0 0 
9-115 4 4 0 1 0 0 0 0 
9-116 12 11 2 1 0 0 0 1 
9-119 9 9 3 2 0 0 0 2 
9-120 11 9 2 2 1 0 0 0 
9-121 7 7 0 1 0 0 0 0 
9-122 16 14 1 3 0 0 0 0 
9-123 6 6 0 1 0 0 0 0 
9-126 10 8 2 5 1 0 1ᵇ 0 
9-129 5 4 1 1 0 0 0 0 
9-130 15 13 2 3 0 0 0 1 
9-145 21 16 6 8 1 0 0 1 
9-174 4 4 1 3 1 0 2 2 
9-176 3 3 1 0 0 0 0 0 
9-179 12 10 2 2 0 0 0 0 
9-182 5 5 0 0 0 0 0 0 
9-183 13 11 2 3 0 0 0 0 
9-186 6 5 1 1 0 0 0 0 
9-187 6 6 2 0 0 0 0 0 
9-190 11 10 2 2 0 0 0 2 
9-193 5 5 0 1 0 0 0 0 
9-194 17 13 6 5 1 0 0 1 
9-198 6 6 0 1 0 0 0 0 
9-199 4 5 1 4 0 0 0 1 
9-200 7 7 0 1 0 0 0 0 
9-204 6 6 0 0 0 0 0 0 
9-205 8 7 1 0 0 0 0 0 
9-210 5 4 1 1 0 0 0 0 
9-212 8 8 0 3 0 0 0 0 
9-219 4 2 2 2 0 0 0 0 
9-220 16 14 2 4 0 0 0 0 
9-221 6 3 4 4 0 1 1 1 
Total 295 260 52 72 5 1 3 14 
Mean 8 7 1 2 0 0 0 0 
S.D. 4.48 3.65 1.48 1.80 0.36 0.17 0.38 0.65 
ᵃ One of these 2 cells had too many color junctions to count. 
ᵇ This cell had too many color junctions to count 
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To compare aberration frequencies among the subjects, metaphase cell counts 
were converted to cell equivalents (CEs). Table 8 shows the total number of CEs scored 
per donor, and the frequency of each type of aberration per 100 CEs. The frequencies 
of aberrant cells and translocated chromosomes per 100 CEs ranged from 0.29 to 2.17, 
and 0.30 to 2.76, respectively. The frequencies of insertions and rings in this data set 
are very low, therefore these aberration types were not evaluated further.  
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Table 8. Aberrations per 100 Cell Equivalents (CEs)*.  
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9-102 1016 0.49 0.00 0.89 0.79 0.10 0.00 0.00 0.00 
9-104 1019 1.47 0.10 2.35 1.96 0.20 0.39 0.00 0.00 
9-105 1011 0.69 0.10 2.28 1.29 0.20 0.69 0.00 0.00 
9-110 1120 0.54 0.00 0.71 0.63 0.09 0.18 0.00 0.00 
9-115 1010 0.49 0.00 0.79 0.79 0.00 0.10 0.00 0.00 
9-116 1015 1.18 0.10 2.56 2.17 0.20 0.10 0.00 0.00 
9-119 1008 0.89 0.20 2.38 1.59 0.30 0.20 0.00 0.00 
9-120 1015 1.18 0.00 2.07 1.58 0.20 0.20 0.10 0.00 
9-121 1010 0.69 0.00 1.58 1.48 0.00 0.10 0.00 0.00 
9-122 1015 1.67 0.00 2.95 2.66 0.10 0.39 0.00 0.00 
9-123 1011 0.59 0.00 1.09 0.99 0.00 0.10 0.00 0.00 
9-126 1009 1.29 0.00 1.98 1.39 0.20 0.50 0.10 0.00 
9-129 1018 0.49 0.00 0.98 0.79 0.10 0.10 0.00 0.00 
9-130 1046 1.43 0.10 2.87 2.20 0.19 0.29 0.00 0.00 
9-145 1016 2.17 0.10 4.92 2.76 0.79 0.98 0.10 0.00 
9-174 1016 0.49 0.20 3.45 0.79 0.10 0.79 0.10 0.00 
9-176 1018 0.29 0.00 0.49 0.39 0.10 0.00 0.00 0.00 
9-179 1015 1.18 0.00 2.17 1.77 0.20 0.20 0.00 0.00 
9-182 1012 0.49 0.00 0.99 0.99 0.00 0.00 0.00 0.00 
9-183 1010 1.39 0.00 2.18 1.78 0.20 0.30 0.00 0.00 
9-186 1013 0.69 0.00 1.09 0.99 0.10 0.10 0.00 0.00 
9-187 1336 0.45 0.00 0.90 0.75 0.15 0.00 0.00 0.00 
9-190 1012 1.09 0.20 2.47 1.48 0.20 0.20 0.00 0.00 
9-193 1013 0.59 0.00 0.89 0.89 0.00 0.10 0.00 0.00 
9-194 1013 1.78 0.10 3.85 2.37 0.59 0.69 0.10 0.00 
9-198 1013 0.69 0.00 1.38 1.38 0.00 0.10 0.00 0.00 
9-199 1012 0.79 0.10 0.79 0.89 0.10 0.59 0.00 0.00 
9-200 1015 0.79 0.00 1.08 0.98 0.00 0.10 0.00 0.00 
9-204 1011 0.59 0.00 1.19 1.19 0.00 0.00 0.00 0.00 
9-205 1020 0.78 0.00 1.27 1.18 0.10 0.00 0.00 0.00 
9-210 1016 0.49 0.00 0.89 0.69 0.10 0.10 0.00 0.00 
9-212 1016 1.08 0.00 1.48 1.48 0.00 0.30 0.00 0.00 
9-219 1012 0.40 0.00 0.59 0.30 0.20 0.20 0.00 0.00 
9-220 1018 1.67 0.00 2.95 2.56 0.20 0.39 0.00 0.00 
9-221 1018 0.69 0.10 2.65 0.98 0.39 0.98 0.00 0.29 
Total 35,948                  
Mean 1027                 
S.D. 56.96                 
* 1 CE = 0.56 metaphase. 
  
56 
 
 
Table 9 shows the frequencies of cells with translocated chromosomes, color 
junctions, dicentrics and acentric fragments per 100 CEs; these are the dependent 
variables that were used in the regression analyses to determine whether DU exposure 
and other risk factors had an effect on chromosome aberration frequencies. The 
independent variables assessed were urine Uranium concentration, age, lifetime x-ray 
exposure, pack years smoked, and alcohol use. Each dependent variable was 
evaluated separately with each independent variable and the results are shown in Table 
10. Urine Uranium concentration, X-rays, smoking, and alcohol use showed no 
statistically significant relationship with any type of chromosome aberration. Age was 
significant with 4 of the 5 aberration types; the only variable that was not significant was 
cells with acentric fragments per 100 CEs. A significant increase of cells with 
translocated chromosomes with age is evident in Figure 3.2. Similar significant 
increases are seen with dicentrics (Figure 3.3), color junctions (Figure 3.4) and 
abnormal cell frequencies (Figure 3.5).  
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Table 9. Frequency of cells with various aberrations per 100 CEs*.  
Donor 
code 
 Color 
junctions 
Translocated 
chromosomes 
Dicentrics 
Acentric 
fragments 
Rings 
Multi-junction 
chromosomes 
9-102 0.49 0.39 0.10 0.00 0.00 0.00 
9-104 1.08 1.08 0.20 0.39 0.00 0.10 
9-105 0.59 0.59 0.10 0.10 0.00 0.10 
9-110 0.45 0.36 0.09 0.18 0.00 0.00 
9-115 0.40 0.40 0.00 0.10 0.00 0.00 
9-116 1.18 1.08 0.20 0.10 0.00 0.10 
9-119 0.89 0.89 0.30 0.20 0.00 0.20 
9-120 1.08 0.89 0.20 0.20 0.00 0.00 
9-121 0.69 0.69 0.00 0.10 0.00 0.00 
9-122 1.58 1.38 0.10 0.30 0.00 0.00 
9-123 0.59 0.59 0.00 0.10 0.00 0.00 
9-126 0.99 0.79 0.20 0.50 0.00 0.00 
9-129 0.49 0.39 0.10 0.10 0.00 0.00 
9-130 1.43 1.24 0.19 0.29 0.00 0.10 
9-145 2.07 1.58 0.59 0.79 0.00 0.10 
9-174 0.39 0.39 0.10 0.30 0.00 0.20 
9-176 0.29 0.29 0.10 0.00 0.00 0.00 
9-179 1.18 0.99 0.20 0.20 0.00 0.00 
9-182 0.49 0.49 0.00 0.00 0.00 0.00 
9-183 1.29 1.09 0.20 0.30 0.00 0.00 
9-186 0.59 0.49 0.10 0.10 0.00 0.00 
9-187 0.45 0.45 0.15 0.00 0.00 0.00 
9-190 1.09 0.99 0.20 0.20 0.00 0.20 
9-193 0.49 0.49 0.00 0.10 0.00 0.00 
9-194 1.68 1.28 0.59 0.49 0.00 0.10 
9-198 0.59 0.59 0.00 0.10 0.00 0.00 
9-199 0.40 0.49 0.10 0.40 0.00 0.10 
9-200 0.69 0.69 0.00 0.10 0.00 0.00 
9-204 0.59 0.59 0.00 0.00 0.00 0.00 
9-205 0.78 0.69 0.10 0.00 0.00 0.00 
9-210 0.49 0.39 0.10 0.10 0.00 0.00 
9-212 0.79 0.79 0.00 0.30 0.00 0.00 
9-219 0.40 0.20 0.20 0.20 0.00 0.00 
9-220 1.57 1.38 0.20 0.39 0.00 0.00 
9-221 0.59 0.29 0.39 0.39 0.10 0.10 
* 1 CE = 0.56 metaphase. 
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Table 10. Summary of P-Values from Least-Square Regression Analyses  
  Independent variables (evaluated separately) 
Cytogenetic endpoints per 100 
CEs 
Age 
Urine 
Uranium 
concentration
^ 
Lifetim
e X-
rays^ 
Pack-
years 
Alcoho
l Use 
Cells with translocated 
chromosomes 
0.0261 0.425 0.179 0.089 0.630 
Cells with dicentrics 0.0243 0.948 0.262 0.908 0.581 
Cells with acentric fragments 0.135 0.176 0.172 0.481 0.496 
Cells with color junctions 0.0227 0.460 0.090 0.099 0.484 
Abnormal cells 0.0260 0.303 0.107 0.091 0.662 
^ log10 transformed      
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Figure 3.2 Relationship between the number of cells containing translocated 
chromosomes per 100 CEs and Veterans’ age at the time of sample collection. The line 
is the best fit least squares regression (p = 0.026). 
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Figure 3.3 Relationship between the number of cells containing dicentrics per 100 CEs 
and Veterans’ age at the time of sample collection. The line is the best fit least squares 
regression (p = 0.024). 
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Figure 3.4 Relationship between the number of cells containing color junctions per 100 
CEs and Veterans’ age at the time of sample collection. The line is the best fit least 
squares regression (p = 0.023). 
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Figure 3.5 Relationship between the number of abnormal cells per 100 CEs and 
Veterans’ age at the time of sample collection. The line is the best fit least squares 
regression (p = 0.026). 
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The translocation frequencies observed in this study were compared to the 
translocation frequencies in 1933 normal healthy individuals from around the world 
(Sigurdson et al., 2008b). Figure 3.6 shows that the translocation frequencies in the DU 
exposed individuals reported here are very similar to this international population. This 
evidence further supports the results of our analyses which show that urine Uranium 
concentration is not significantly associated with chromosome damage in these 
subjects. 
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Figure 3.6 Baseline translocation frequencies per 100 CEs for a population of 1933 
normal healthy individuals from around the world (Sigurdson et al., 2008) compared to 
the frequencies found in the 35 DU-exposed veterans. The figure was adapted from 
(Tucker and Luckinbill, 2011). Black circles represent DU-exposed individuals in this 
study; open circles represent one individual while filled circles represent 2 individuals 
with the same value. “Translocations” for this figure were counted as 1 reciprocal 
translocation = 1 translocation, and 1 translocated chromosome = 1 translocation; all 
other translocations data in this paper are presented as translocated chromosomes. 
The Veterans in this study are well within the normal background frequencies of 
translocations and are not elevated due to long term DU exposure.  
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DISCUSSION 
No correlations between chronic DU exposure and chromosome aberrations 
were observed in this study. The results of this work are consistent with previous 
studies showing no U-related health effects resulting from exposure to depleted uranium 
in this population (Squibb et al., 2012). Clear trends were seen with respect to age, 
which is a well known factor associated with increased chromosome aberrations. 
Similarly, X-rays, smoking and alcohol use did not show any correlation with 
chromosome damage. The numbers of X-rays are reported by the subjects from 
memory and may not be as accurate as desired, and the cumulative X-ray doses are 
not known. Even if the total X-ray doses were known, they would probably be too low to 
have a measurable effect on chromosome aberration frequencies. In addition, the 
population sample size of 35 individuals makes it hard to discern small effects such as 
those arising from smoking and alcohol use, so it is not surprising that these variables 
(Ramsey et al., 1995; Sigurdson et al., 2008b) showed no statistical significance.  
Urine Uranium levels remain elevated in Veterans with embedded fragments, 
indicating the existence of persistent localized chemical and radiological exposure, 
however the genotoxic effects of DU, if any, are too small to be observed by our 
methods with a population this size. In our previous work, the cytokinesis block 
micronucleus assay was used to enumerate micronuclei (MN) in this same population 
(Bakhmutsky et al., 2011). Thirty participants were analyzed both in that study and in 
the present effort. No statistically significant correlation was observed between the 
frequencies of micronucleated cells and any type of chromosome aberration (data not 
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shown). As in the present work, no association was observed between DU exposure 
and MN levels in our previous study.  
Health risk estimates resulting from DU exposure of U.S. soldiers during the 
1991 Gulf War have been evaluated mathematically (Marshall, 2008), who developed 
models for cancers, birth defects, radiation doses, kidney toxicity, neurotoxic effects and 
bone damage. The results for radiation doses received from DU are well under the 
allowed lifetime limits for radiation workers. The theoretical increased risk from DU 
exposure on cancer development is 1.4% for highly exposed Veterans with retained 
fragments; the US average risk of developing fatal cancer is 24% (Marshall, 2008), so 
this theoretical increase is likely too low to be observed. Most individuals in this DU 
cohort did not experience such high exposures, nor do they have large retained 
fragments, so the long-term health risks based on the currently available data, including 
that presented here, are probably negligible. The risk of radiation or chemically induced 
birth defects is also not significant, according to this modeling, and neither is long term 
kidney damage. The results of this study are consistent with the findings of the DU 
Follow-Up Program. 
 A small study by Schroder et al. (Schroder et al., 2003) examined chromosome 
aberrations in 16 Veterans deployed in the Gulf and/or Balkans who described possible 
but undocumented DU inhalation exposures. Study volunteers were not tested for levels 
of uranium in urine, thus it was difficult to establish whether DU exposure had actually 
occurred. The authors describe an increase in the frequencies of dicentrics and acentric 
ring chromosomes compared to laboratory controls, however other causative factors 
were not examined. 
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Many in vitro studies have evaluated the clastogenic, carcinogenic and 
reproductive effects of DU in cell lines and animal models. DU was shown to be a 
potential human bronchial carcinogen based on in vitro exposures causing chromosome 
instability and aberrations in cultured bronchial epithelial cells (LaCerte et al., 2010; Xie 
et al., 2010). The kidney is thought to be a target organ for DU toxicity. Exposure of rat 
kidney mitochondria to uranyl acetate caused damage to the mitochondrial outer 
membrane, and impairment of the electron chain as well as oxidative stress (Shaki et 
al., 2012). Renal anemia was induced in rats exposed by ingestion to DU for 9 months 
which resulted in kidney deterioration and a 20% reduction in erythrocyte counts 
(Berradi et al., 2008). Rats exposed to 4 months of DU-contaminated food showed 
genotoxic and reproductive effects both in the F0 and F1 generations (Hao et al., 2009, 
2012). All the rats in the above studies were exposed to DU in their food, which is a 
different route of exposure than the inhalation and wound contamination experienced by 
Veterans. Food contamination is an unlikely source of exposure for most human 
populations because environmental contamination by DU is localized and confined to 
where DU munitions were used. Levels and isotopic composition of uranium in food 
samples from the Balkan region where DU-containing weapons were widely employed 
were found to be comparable to those in other European regions where DU was not 
used (Carvalho and Oliveira, 2010). 
Micronucleus formation was investigated in mouse embryonic fibroblasts (MEFs) 
exposed either to enriched uranium (EU) or DU to compare their genotoxic profiles 
(Darolles et al., 2010). Both DU and EU were shown to induce MN formation, however 
DU-induced MN contained centromeres, indicating that DU can be classified as 
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aneugenic as well as clastogenic. While the clastogenic effects of EU were mainly due 
to its radiotoxicity because of the correlation between ionizing radiation doses received 
by cells and the number of micronucleated cells, the effect of DU was due to its 
chemotoxicity where no such correlation between radiation dose and MN formation 
could be established.  
Another study presented evidence that normal background gamma radiation 
could interact with embedded DU particles in the human body to produce an enhanced 
dose of radiation to the surrounding tissue due to the photo-electric absorption of the 
radiation by DU metal. However, the radiation dose from these DU particles has been 
determined to be negligible (Pattison, 2013) and not likely to raise the lifetime cancer 
risk significantly.  
We observed 6 cells with unusually high amounts of chromosome damage, each 
of which had more than 10 color junctions. These types of cells have been termed 
multidamaged or rogue cells in the literature (Neel et al., 1992; Sevan'kaev et al., 1993). 
No clear-cut definition of rogue cells exists, but they are generally defined as cells with 
excess chromosome-type damage with a prevalence of acentric fragments and 
multicentric chromosomes. The damage in these cells varies from a few breaks to 
cases where the number of aberrations cannot readily be determined due to their 
complexity, such as in 2 of the 6 cells found here. Rogue cells appear to be non-
randomly distributed in individuals. Two participants in our study had 2 such cells and 
the other 2 subjects had one each. Rogue cells appear to be transient in individuals, 
more rogue cells may or may not be found in subsequent sampling (Neel et al., 1992). 
Rogue cells show no correlation with radiation exposure and are just as readily found in 
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controls as in radiation exposed individuals (Lazutka, 1996; Mustonen et al., 1998; 
Sevan'kaev et al., 1993). The direct causes of rogue cells are still unknown but this 
phenomenon has been observed in many cytogenetic studies around the world 
(Mustonen et al., 1998). We observed no association between urine Uranium levels and 
the incidence of heavily damaged or rogue cells in our population. 
Here we have shown there is no correlation between any type of structural 
chromosome aberration and urine Uranium levels, smoking, or alcohol use in US 
Veterans of Gulf War I. However, age was found to be significantly associated with most 
types of chromosome damage. These results indicate that long term depleted uranium 
exposure does not cause increased rates of chromosome damage in Gulf War I 
Veterans.  
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CHAPTER 4 
CYTOGENETIC SUSCEPTIBILITY TO IONIZING RADIATION IN NEWBORNS AND 
ADULTS 
INTRODUCTION 
Structural chromosome aberrations are a well known biomarker of exposure to 
clastogenic agents such as ionizing radiation and can be helpful in determining cancer 
susceptibility rates. Chromosome damage is also a biomarker of the effect of clastogens 
on human cells. Aberrations such as translocations are useful and important for 
evaluation of chronic exposures. Translocations are the most stable chromosome 
rearrangement because they are compatible with cell division. For this reason 
translocations can persist for years and have been used to assess chronic and 
temporally-displaced exposure (Jones et al., 2001; Tucker et al., 1997). Cells containing 
unstable aberrations such as dicentrics, fragments, and rings are eliminated quickly 
because they are strongly selected against in mitosis, but they are a useful marker of 
recent acute exposures.  
Baseline chromosome aberration frequencies, especially translocations, are well 
known to increase with age (Ramsey et al., 1995; Sigurdson et al., 2008b). Aberrations 
accumulate in older individuals due to many possible factors such as lifetime cumulative 
low level exposures to external and internal environmental agents, telomere shortening 
(Soler et al., 2009), free radicals, accumulation of misrepaired genome lesions, and 
cellular senescence (Sabin and Anderson, 2011). Cells with chromosome aberrations 
may not necessarily develop into cancer cells (Mladinic et al., 2010) but increased 
aberration levels are well known indicators of increased cancer risk (Bonassi et al., 
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2008; Hagmar et al., 1998). Radiation exposures, a common cause of aberration 
formation, increase the overall lifetime risk of developing cancer as seen in atomic 
bomb survivors (Pierce and Mendelsohn, 1999). Cancer risks in background and 
exposed individuals both increase with age. Children exposed to radiation have a higher 
lifetime risk for developing cancers due to having more rapidly dividing cells that can 
propagate DNA damage such as chromosome aberrations throughout a longer 
remaining lifetime than an adult (Shah et al., 2012). When an adult is exposed to 
ionizing radiation, their induced cancer risk remains relatively stable and does not 
decline as age at exposure increases (Shuryak et al., 2010).  
Radiation-induced cancer risk is a consequence of DNA damage but cannot be 
directly extrapolated from the effects of radiation-induced chromosome aberrations. 
However, not much is known about whether cellular responses to ionizing radiation 
change as a factor of the ageing process. Rodent models exposed to radiation at 
different stages of life show a higher sensitivity for ionizing radiation at the birth to 
weaning period and decreasing in adulthood (Hattis et al., 2004). 
To our knowledge, this is the first cytogenetic study that has systematically 
evaluated changes in susceptibility to ionizing radiation for people of different ages. 
Here we show that cord blood obtained from newborns is significantly more susceptible 
to radiation-induced structural chromosome aberrations than is peripheral blood 
obtained from adults. Among adults however, no significant change in response to 
radiation was observed with age. The findings of this work may influence future risk 
assessment for ionizing radiation exposure in people of all ages. 
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MATERIALS AND METHODS 
Recruitment of Subjects and Blood Collection 
 Prior approval for this use of human subjects was obtained from the Wayne State 
University (WSU) Human Investigations Committee for both adult and newborn donors. 
Adult subjects were recruited from the WSU campus and surrounding areas. Subjects 
filled out a health questionnaire (provided in Appendix A) which inquired about age, 
gender, smoking and alcohol use. Peripheral blood samples were drawn into 6 mL 
Vacutainer Sodium Heparin tubes (Becton Dickinson) at the Campus Health Center by 
a registered nurse. Samples and questionnaires were coded immediately and 
transported to the cytogenetics laboratory within 30 minutes following phlebotomy. 
Blood samples from full-term newborns were collected by a nurse or physician 
from the fetal side of the placenta and / or from umbilical cords (hereafter referred to 
simply as “cord” blood) into 6 mL BD Vacutainer Sodium Heparin tubes with prior 
consent of the newborns’ mothers. All deliveries occurred at the Hutzel-Webber 
Hospital, Detroit Medical Center, which is affiliated with WSU. After collection the 
samples were kept at 4°C for less than 24 hours before transporting the tubes in an 
insulated container via a 5 minute walk to the Gershenson Radiation Oncology Center 
at the Karmanos Cancer Institute.  
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Cell Culturing, Irradiation, Slide Preparation And FISH Painting  
 Adult blood samples were split into five T25 suspension flasks with plug caps 
(CELLSTAR) and transported in an insulated container by car to the Gershenson 
Radiation Oncology Center, a distance of approximately 1 km from the cytogenetics 
laboratory. Cord blood samples were also split into the same number and type of flasks 
at the Radiation Oncology Center. All flasks were acutely irradiated with Cobalt-60 
gamma rays at 1, 2, 3 and 4 Gy. The 0 Gy (control) flasks traveled with the other 
samples but were not irradiated. 
All samples were then transported back to the cytogenetics laboratory, where 
800 L of blood was dispensed into T25 flasks containing 10 mL of RPMI 1640 medium 
(Hyclone), supplemented with 15% Fetal Bovine Serum (Atlanta Biologicals), penicillin–
streptomycin (100 units/mL penicillin G sodium, 100 g/mL streptomycin in 0.85% 
saline, Gibco), 2% PHA (Gibco) and 2 mM L-glutamine (Gibco) that had been pre-
warmed to 37C. Two T25 suspension flasks with vented caps (CELLSTAR) were set 
up for each dose and donor. Culture flasks were placed upright in a fully humidified 
incubator with 5% CO2 at 37C for 48 hrs. KaryoMAX Colcemid solution (10 g/mL, 
Gibco) was added at a final concentration of 0.1 g/mL 4 hours prior to the end of 
culture to arrest cells in metaphase. The cells were then gently re-suspended and 
decanted into 15 mL conical tubes, and centrifuged at 1400 RPM for 5 min at room 
temperature. The supernatant was aspirated and the cell pellets gently resuspended in 
8 mL 75 mM KCL solution pre-warmed to 37C and incubated for 30 minutes at 37C. 
Two mL of freshly prepared fixative (methanol:acetic acid 3:1 v/v) solution was added to 
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each tube, mixed well and centrifuged at 1400 RPM for 5 minutes. The supernatant was 
again aspirated and the cells were washed three times with 2 mL of fixative. To make 
metaphase spreads the pellet was resuspended in a few drops of pure glacial acetic 
acid and cells were dropped onto ethanol-cleaned cold glass microscope slides over a 
70C water bath. 
 Slides were aged overnight at room temperature and subsequently stored in N2 
gas with a desiccant pack at -20C. As needed, slides were returned to room 
temperature and hybridized with FISH Whole Chromosome Painting kits from Cambio 
or Applied Spectral Imaging following the manufacturers’ protocols. Chromosomes 1, 2, 
and 4 were hybridized with a Cy3 labeled probe and chromosomes 3, 5, and 6 were 
simultaneously labeled with FITC. Slides were mounted with 50 L ProLong Gold 
antifade reagent with DAPI (Invitrogen) and a glass coverslip and left to cure for 24 
hours at 4C. The chromosome paints from both manufacturers were tested and found 
to be comparable in quality and signal strength.  
 
Slide Coding and Cell Scoring 
Individual slides for each donor and dose were coded after hybridization and 
before being scored. Approximately 1800, 900, 540, 180 and 180 metaphase cells, 
which correspond to 1000, 500, 300, 100 and 100 cell equivalents (1 CE = 0.56 
metaphase cells) (Tucker, 2010b) were scored for each subject for the 0, 1, 2, 3 and 4 
Gy doses, respectively. All slides were scored by trained observers using epifluorescent 
microscopes. Coordinates and digital photographs were recorded for all abnormal cells. 
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Every chromosome aberration in each abnormal cell was double checked by an expert 
cytogeneticist to assure accuracy and consistency across slide readers in the 
identification of chromosome damage.  
All structural chromosome abnormalities were initially recorded using the PAINT 
nomenclature system (Tucker et al., 1995). Adjacent pieces of a chromosome labeled in 
different colors were recorded as color junctions. Each chromosome containing one 
centromere and one color junction was counted as a translocated chromosome. 
Dicentrics, acentric fragments, insertions, centric and acentric ring chromosomes and 
abnormal cells were also recorded. Aberrant chromosomes with 2 or more junctions are 
referred to here as multi-junction chromosomes; examples include (ACb), (BCaC), 
(CbC), (CABA), where A, B and C are portions of chromosomes painted blue, red and 
green respectively, and capital letters indicate chromosome material with a centromere 
(Tucker et al., 1995). Many multi-junction aberrant chromosomes were found at the 
higher doses, and these were divided into their corresponding simple aberrations for 
use in subsequent analyses. For example, a chromosome identified as (AbC) was 
counted as 2 translocated chromosome events (Ab) and (bC), and (CBa) was counted 
as a dicentric (CB) and a translocated chromosome (Ba). While insertions fit the 
definition of a multi-junction chromosome, they were categorized separately.  
A mitotic index for each donor was obtained using control (0 Gy) slides stained 
with Giemsa. Scoring for all 30 samples was performed by one well-trained observer 
under a light microscope.  
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Statistical Analysis 
Univariate and multivariate regression analyses were performed to determine 
whether age is a significant factor in individual susceptibility to radiation-induced 
chromosome damage. Initial exploratory analyses were performed for each of the 
dependent variables, i.e., the frequencies per 100 CEs of translocated chromosomes, 
dicentrics, acentric fragments, rings, insertions, color junctions, and abnormal cells, 
which were regressed in multivariate analyses against the independent variables of 
dose, dose-squared, and age. As expected, dose and dose-squared were major factors 
in determining the frequency of each cytogenetic endpoint. In most of these analyses 
the effect of age was also found to be statistically significant, except for rings and 
insertions, for which comparatively fewer events were seen. Subsequent regression 
analyses incorporated an interaction term for age and dose (or dose-squared) and this 
interaction term was in many cases also found to be significant.  
We then sought to determine which dose(s) (i.e., 0, 1, 2, 3, and / or 4 Gy) were 
responsible for the age effect. Here, regression analyses for each aberration type were 
performed individually with each dose using age as the sole independent variable. The 
frequencies of all aberration types except insertions and rings were found to increase 
with age in the control (0 Gy) group, consistent with published reports (Ramsey et al., 
1995; Sigurdson et al., 2008b). In contrast, aberration frequencies in the irradiated 
samples generally declined with age. The slopes of the regression lines in the control (0 
Gy) group were in the opposite direction from those of the irradiated samples and we 
wanted to evaluate the frequencies of events induced by radiation to better understand 
the susceptibility to ionizing radiation in our samples. To obtain the frequency of induced 
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events we subtracted the frequency of events in the control (0 Gy) group for each 
cytogenetic endpoint from the total frequencies of cytogenetic events. We then 
regressed these induced values for each endpoint with age as the sole independent 
variable for each dose.  
The effects of other independent variables (gender, ethnicity, cigarette smoking, 
and alcohol use) were evaluated using univariate regression analyses.  
All analyses were performed using JMP software, version 6.0, SAS Institute Inc. 
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RESULTS 
 A total of 20 healthy adult and 10 newborn cord blood samples were evaluated 
with FISH whole chromosome painting for chromosome damage after receiving acute 
doses of 0 (control), 1, 2, 3 or 4 Gy of Cobalt-60 gamma rays. Table 11 shows the 
demographics of the study population including age at time of blood draw and gender. 
For the adult donors, self-reported race, pack years smoked, and alcoholic drinks per 
week are also provided. Cord blood donors' chromosomal sex was determined by the 
presence or absence of a Y chromosome in FISH painted metaphase cells 
counterstained with DAPI. No other data were obtained from the mothers of the 
newborns in regards to ethnicity, drinking, or smoking during pregnancy.  
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Table 11. Demographic characteristics of the 30 study participants. 
Donor # Age Gender Ethnicity 
Pack 
years 
Alcohol 
drinks per 
week 
Adults           
1 26 M Asian 0ᵃ 25 
2 35 M African-American 0 6 
3 44 M White 0ᵇ 1 
4 56 F White 0 1.5 
5 67 F White 24 0.1 
6 78 F White 20 1 
7 22 F African-American 6ᶜ 8 
8 48 M Asian 0 0 
9 75 M White 2 14 
10 39 M Mexican-American 0 3 
11 67 M White 0 5 
12 68 F White 0 0 
13 62 M African-American 40 6 
14 57 F African-American 0 2 
15 24 M African-American 3ᶜ 10 
16 29 M White 2.5 2 
17 32 M White 0 0.5 
18 47 M African-American 15 6.5 
19 53 M African-American 0 4 
20 49 F White 3.5 12 
 
Cord Bloods d 
    
21 0 F  -  -  - 
22 0 M  -  -  - 
23 0 F  -  -  - 
24 0 M  -  -  - 
25 0 M  -  -  - 
26 0 F  -  -  - 
27 0 F  -  -  - 
28 0 M  -  -  - 
29 0 M  -  -  - 
30 0 F  -  -  - 
ᵃ Occasional pipe/hookah use. 
ᵇ Occasional chewing tobacco use.   
ᶜ Years of smoking, amount of cigarettes per day not specified. 
d Data for ethnicity, and pack-years and alcohol use during pregnancy 
were not obtained. 
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  Table 12 shows the number of metaphase cells scored by dose group for adults 
and for newborns. The numbers of translocated chromosomes, dicentrics, acentric 
fragments, color junctions, insertions, centric and acentric rings that were observed are 
also shown. Metaphase cells were converted to cell equivalents (1 CE = 0.56 
metaphase cell) to enable direct comparisons to be made of frequencies of different 
types of aberrations among donors.  
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Table 12. Number of normal and abnormal cells, and number of structural chromosome 
aberrations for adults and newborns. 
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Adults            
0 42,183  23,622  41,969  214 278 40 60 348 4 5 1 
1 19,500  10,920  17,304  2,196  1,885  688  1,302  3,330  19 60 13 
2 11,526  6,455  7,725  3,801  3,769  1,589  2,885  7,080  44 105 35 
3 4,108  2,213  1,630  2,478  3,027  1,393  2,423  5,636  49 87 19 
4 3,812  2,134  731  3,081  4,946  2,133  4,187  9,696  136 169 25 
Total 81,129  45,344  69,359  11,770  
  
 
         
 
Cord Bloods 
 
                    
0 18,560  10,394  18,543  17 8 3 11 14 0 1 0 
1 9,401  5,265  8,131  1,270  1,158  282  738  2,146  10 15 2 
2 5,508  3,084  3,555  1,953  2,180  571  1,527  4,073  19 34 5 
3 1,950  1,092  761  1,189  1,668  472  1,246  3,195  20 30 6 
4 1,967  1,102  439  1,528  2,822  820  2,026  5,405  75 47 10 
Total 37,386  20,936  31,429  5,957  
  
 
            
Grand 
Total 
118,515  66,280  100,788  17,727  
  
 
 
            
^ 1 Cell equivalent = 0.56 metaphase cell 
* Includes data from multi-junction chromosomes 
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 Figures 4.1-4.7 show the dose response curves for different cytogenetic 
endpoints for individual donors and as a summary comparison between adult and cord 
blood donor groups. Figure 4.1 shows that adults and newborns have similar numbers 
of abnormal cells after radiation exposure. Newborns as a group have significantly more 
translocated chromosomes (Figure 4.2) and color junctions (Figure 4.5) than adults but 
fewer dicentrics (Figure 4.3) and rings (Figure 4.7). Acentric fragments and insertions 
show no difference between the groups (Figures 4.4 and 4.6 respectively). Mitotic 
indices were determined for all control (0 Gy) samples (Figure 4.8). Newborns have 
significantly more mitotic cells compared to adults which likely explains some of the 
differences between the dose response curves.  
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a) 
 
b)  
 
c) 
 
Figure 4.1 Abnormal cells per 100 CEs by dose for newborns and adults, by group and 
individual. a) Abnormal cells per 100 CEs by dose of Cobalt-60 gamma rays for 
newborns and adults. Blue diamonds: mean abnormal cells for 20 adults; red squares: 
mean abnormal cells for 10 cord blood samples. Vertical lines are standard errors and 
are too small to be clearly visible for some doses. There is no significant difference 
between adults and newborns for this endpoint. Curves are slightly offset for clarity. b) 
Abnormal cells per 100 CEs in individual adults by dose. c) Abnormal cells per 100 CEs 
in individual newborns by dose.    
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a) 
 
b) 
 
c) 
 
Figure 4.2 Translocated chromosomes per 100 CEs by dose for newborns and adults, 
by group and individual. a) Translocated chromosomes per 100 CEs by dose of Cobalt-
60 gamma rays for newborns and adults. Blue diamonds: mean translocated 
chromosomes for 20 adults; red squares: mean translocated chromosomes for 10 cord 
blood samples. Vertical lines are standard errors and are too small to be clearly visible 
for some doses. Newborns show a significant increase in translocated chromosomes 
compared to adults (p < 0.025). Curves are slightly offset for clarity. b) Translocated 
chromosomes per 100 CEs in individual adults by dose. c) Translocated chromosomes 
per 100 CEs in individual newborns by dose.  
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a) 
 
b) 
 
c) 
 
Figure 4.3 Dicentrics per 100 CEs by dose for newborns and adults, by group and 
individual. a) Dicentrics per 100 CEs by dose of Cobalt-60 gamma rays for newborns 
and adults. Blue diamonds: mean dicentrics for 20 adults; red squares: mean dicentrics 
for 10 cord blood samples. Vertical lines are standard errors and are too small to be 
clearly visible for some doses. Adults show a significant increase in dicentrics over 
newborns (p < 0.00046). Curves are slightly offset for clarity. b) Dicentrics per 100 CEs 
in individual adults by dose. c) Dicentrics per 100 CEs in individual newborns by dose.   
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a) 
 
b) 
 
c) 
 
Figure 4.4 Acentric fragments per 100 CEs by dose for newborns and adults, by group 
and individual. a) Acentric fragments per 100 CEs by dose of Cobalt-60 gamma rays for 
newborns and adults. Blue diamonds: mean acentric fragments for 20 adults; red 
squares: mean acentric fragments for 10 cord blood samples. Vertical lines are 
standard errors and are too small to be clearly visible for some doses. There is no 
statistically significant difference between adults and newborns for this endpoint. Curves 
are slightly offset for clarity. b) Acentric fragments per 100 CEs in individual adults by 
dose. c) Acentric fragments per 100 CEs in individual newborns by dose.   
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a) 
 
b) 
 
c) 
 
Figure 4.5 Color junctions per 100 CEs by dose for newborns and adults, by group and 
individual. a) Color junctions per 100 CEs by dose of Cobalt-60 gamma rays for 
newborns and adults. Blue diamonds: mean color junctions for 20 adults; red squares: 
mean color junctions for 10 cord blood samples. Vertical lines are standard errors and 
are too small to be clearly visible for some doses. There is a significant increase in color 
junctions for newborns compared to adults (p < 0.0046). Curves are slightly offset for 
clarity. b) Color junctions per 100 CEs in individual adults by dose. c) Color junctions 
per 100 CEs in individual newborns by dose.   
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a) 
 
b) 
 
c) 
 
Figure 4.6 Insertions per 100 CEs by dose for newborns and adults, by group and 
individual. a) Insertions per 100 CEs by dose of Cobalt-60 gamma rays for newborns 
and adults. Blue diamonds: mean insertions for 20 adults; red squares: mean insertions 
for 10 cord blood samples. Vertical lines are standard errors and are too small to be 
clearly visible for some doses. There is no statistically significant difference in the levels 
of insertions between adults and newborns. Curves are slightly offset for clarity. b) 
Insertions per 100 CEs in individual adults by dose. c) Insertions per 100 CEs in 
individual newborns by dose. 
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a) 
 
b) 
 
c) 
 
Figure 4.7 Rings per 100 CEs by dose for newborns and adults, by group and 
individual. a) Total acentric and centric rings per 100 CEs by dose of Cobalt-60 gamma 
rays for newborns and adults. Blue diamonds: mean rings for 20 adults; red squares: 
mean rings for 10 cord blood samples. Vertical lines are standard errors and are too 
small to be clearly visible for some doses. Adults show a significant increase in rings 
compared to newborns (p = 0.0015). Curves are slightly offset for clarity. b) Acentric 
fragments per 100 CEs in individual adults by dose. c) Acentric fragments per 100 CEs 
in individual newborns by dose. 
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Figure 4.8 Mitotic index data for adult and newborn cell populations. Newborns show a 
significantly increased number of cells in mitosis per 1000 cells compared to adults 
(p=0.0055).  
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Baseline chromosome aberration frequencies by age for unexposed samples (0 
Gy) are shown in Figure 4.9. Statistically significant increases in translocated 
chromosomes, dicentrics, acentric fragments, color junctions and abnormal cells are 
seen here with respect to age, which are consistent with previous published studies 
(Ramsey et al., 1995; Sigurdson et al., 2008b). Figures 4.10–4.16 show the aberration 
frequencies by age at each radiation dose. Since these frequencies decline with age 
and baseline (i.e. unirradiated) frequencies increase with age, the frequencies of 
induced aberrations were obtained by subtracting the frequencies of aberrations in 
unirradiated cultures from the total aberrations to obtain a clearer view of the 
susceptibility to radiation by age. Even though age is a statistically significant factor 
when the baseline data are not subtracted, the effect of age is enhanced when induced 
values are evaluated. Cord blood samples show increased susceptibility to 
chromosome damage after irradiation compared to adults receiving the same dose.  
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a) p<0.0001 
 
 
b) p=0.0112 
 
 
c) p=0.0006 
 
 
d) p<0.0001 
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e) p<0.0001 
 
 
f) Not significant 
 
 
g) Not significant 
 
 
Figure 4.9 Baseline (0 Gy) chromosome aberrations per 100 CEs by age in unexposed 
blood samples. Lines are least square linear regressions. All slopes are statistically 
significant except for rings (f) and insertions (g). 
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a) 1 Gy p=0.0028 
 
 
b) 2 Gy p=0.0076 
 
 
c) 3 Gy p=0.0114 
 
 
 d) 4 Gy Not significant 
 
 
Figure 4.10 Induced translocated chromosomes per 100 CEs by age with the baseline 
(0 Gy) values subtracted. Lines are least square linear regressions All slopes are 
statistically significant except for 4 Gy (d).  
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a) 1 Gy p=0.0002 
 
 
b) 2 Gy Not significant 
 
 
c) 3 Gy p=0.0195 
 
 
d) 4 Gy Not significant 
 
 
Figure 4.11 Induced dicentrics per 100 CEs by age with the baseline (0 Gy) values 
subtracted. Two slopes are statistically significant: 1 Gy (a) and 3 Gy (c); two are not 
significant: 2 Gy (b) and 4 Gy (d). 
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a) 1 Gy p=0.0162 
 
 
b) 2 Gy Not significant 
 
 
c) 3 Gy Not significant 
 
 
d) 4 Gy Not significant 
 
 
Figure 4.12 Induced acentric fragments per 100 CEs by age with the baseline (0 Gy) 
values subtracted. None of the slopes are statistically significant except for 1 Gy (a). 
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a) 1 Gy p=0.0032 
 
 
b) 2 Gy Not significant 
 
 
c) 3 Gy Not significant 
 
 
d) 4 Gy Not significant 
 
 
Figure 4.13 Induced aberrant cells per 100 CEs by age with the baseline (0 Gy) values 
subtracted. None of the slopes are statistically significant except for 1 Gy (a). 
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a) 1 Gy p=0.0003 
 
 
b) 2 Gy p=0.0115 
 
 
c) 3 Gy p=0.0062 
 
 
d) 4 Gy Not significant 
 
 
Figure 4.14 Induced color junctions per 100 CEs by age with the baseline (0 Gy) values 
subtracted. All slopes are statistically significant except for 4 Gy (d). 
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a) 1 Gy Not significant 
 
 
b) 2 Gy Not significant 
 
 
c) 3 Gy Not significant 
 
 
d) 4 Gy p=0.0438 
 
 
Figure 4.15. Induced total (i.e., acentric plus centric) rings per 100 CEs by age with the 
baseline (0 Gy) values subtracted. None of the slopes are statistically significant except 
for 4 Gy (d). 
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a) 1 Gy Not significant 
 
b) 2 Gy Not significant 
 
c) 3 Gy Not significant 
 
d) 4 Gy Not significant 
 
Figure 4.16 Induced insertions per 100 CEs by age with the baseline (0 Gy) values 
subtracted. None of the slopes are statistically significant. 
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 Induction of chromosome damage is only significant by age when the newborn 
group is included. When adult data are evaluated separately without the newborns, 
none of the cytogenetic endpoints show any statistical significant effect with age. The 4 
Gy dose is not significant for any endpoint, which is most likely due to the variability 
among individual donors (see panels b and c in Figures 4.1-4.7) but follows the same 
downward trend as the other doses. The age effect is still generally present when the 4 
Gy dose, both 3 and 4 Gy doses, and when the 2, 3 and 4 Gy dose groups are dropped 
from the analyses (data not shown), indicating that the age effect is not confined to the 
high doses. There is no statistically significant effect of gender, race, smoking, or 
alcohol use on any of the cytogenetic endpoints (data not shown).  
 The magnitude of the increased susceptibility in newborns is shown in Figure 
4.17 which shows the ratio of aberrations in newborns compared to adults at each dose. 
Ratios equal to 1 indicate an equal response to radiation, i.e., no difference in 
susceptibility, while ratios greater than 1 indicate an increase in susceptibility. The 
highest susceptibility is seen at 1 Gy where newborns have a 38% increase in induced 
aberrations compared to adults.  
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Figure 4.17 Ratios of induced chromosome aberrations in newborns compared to 
adults at each dose. The ratios of the frequencies of translocated chromosomes, 
dicentrics, acentric fragments and color junctions are shown as well as the average of 
these 4 endpoints (black line). The average susceptibility in newborns is greater than 1 
at all 4 doses, i.e., 1.38 at 1 Gy, 1.19 at 2 Gy, 1.12 at 3 Gy and 1.05 at 4 Gy. 
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DISCUSSION 
The major findings of this work improve our understanding of the susceptibility of 
people of different ages to ionizing radiation. Our results indicate that newborns have 
elevated susceptibility to radiation-induced chromosome damage in peripheral blood 
lymphocytes compared to adults, and suggest that the induction of structural 
chromosome damage is an inherent component of this susceptibility. We also show that 
susceptibility to radiation-induced chromosome damage does not change with age 
among adults. These findings support previous work showing that children are at higher 
risk of developing cancer associated with radiation exposure (Kleinerman, 2006; 
Sadetzki and Mandelzweig, 2009).  
The existence of increased susceptibility in newborns and the absence of an age 
effect in adults both challenge and simplify risk estimation for people of different ages. 
Even though an age effect was not evident among adults, inter-individual variation due 
to intrinsic genetic factors may still influence radiation responses (Schnarr et al., 2007). 
The findings reported here suggest that the change in susceptibility with age appears to 
occur between birth and adulthood. The question remains at what age children change 
in their susceptibility to radiation-induced damage and whether this change is gradual or 
occurs at specific developmental milestone(s) such as puberty. One study showed that 
children aged 0.4 to 9 years had increased dicentric yields directly after a low dose 
exposure to ionizing radiation via a CT scan compared to children aged 10 to 15 years 
where no significant increase was observed (Stephan et al., 2007). Their work is 
consistent with our findings of increased susceptibility in newborns and also points to a 
decrease in susceptibility by the time a child reaches approximately 10 years of age.  
104 
 
 
The frequencies of all baseline (0 Gy) aberrations except rings and insertions 
were found to increase significantly with age, which is consistent with published 
observations (Ramsey et al., 1995; Sigurdson et al., 2008b). These results clearly show 
that this study has enough statistical power to confirm a known response even with a 
relatively modest sample size. Cigarette smoking has been previously shown to 
increase the frequencies of chromosome aberrations (Sigurdson et al., 2008b) but not 
every study has observed this effect, e.g., (Bennett et al., 2010), a disparity which may 
be attributable to differences in the amount of smoking among these populations. In the 
present study we did not observe a significant smoking effect.  
There is some debate in the literature about the definition of a “translocation” 
when reporting chromosome aberrations induced by adverse exposure. Translocations 
have historically been viewed as a reciprocal exchange of genetic material between 
exactly 2 chromosomes such that each resulting chromosome contains one centromere 
and one segment of the other chromosome; this aberration arises due to mis-repair of 
double strand breaks and is commonly called a “reciprocal translocation”. At increasing 
doses of radiation, often more than 2 DNA double strand breaks occur simultaneously in 
a single cell resulting in more complex rearrangements called multi-way exchanges. We 
did observe and count reciprocal translocations but cells with multiple aberrations that 
included one or more non-reciprocal translocations were commonly seen, especially at 
the higher doses. Here we have used the term translocated chromosome to denote 
structurally rearranged chromosomes that have a single centromere. These 
translocated chromosomes arise from multi-way exchanges (Giannico et al., 2009) 
resulting from mis-repair and can become very complex (Loucas and Cornforth, 2001; 
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Tucker, 2010b; Tucker et al., 1995). Our approach for categorizing individual rearranged 
chromosomes has been described previously (Tucker et al., 1995). Here we cannot 
elucidate the mechanism(s) of formation of these complex aberrations, but we can 
clearly see the results of the mis-repair by cells in the form of these exchanges.  
There are too few occurrences of ring chromosomes and insertions to see any 
significant change with age. Rings do exhibit a statistically significant effect at the 4 Gy 
dose, but here their frequencies increased with age compared to the other aberration 
types which declined with age. There are very few rings and insertions at the lower 
doses, so to characterize the relationship between rings and age we would either need 
data from doses higher than 4 Gy or we would need to score many more cells at the 
lower doses. Mechanistically, the cytogenetic counterpart of ring chromosomes is 
inversions, but inversions could not be observed with the painting method used here. If 
we had been able to see inversions as well as rings, combining these aberration 
frequencies might have provided enough statistical power at the lower doses to see an 
age effect.  
When the adults were evaluated separately without the newborns, no age-related 
differences were observed in the frequencies of induced chromosome aberrations. This 
finding points to a change in susceptibility somewhere between birth and young 
adulthood rather than a gradual change over the years from birth to senescence. The 
lack of an age effect among adults is perhaps the result of the completion of growth and 
development. More data are needed at ages 70 and above to evaluate the effect, if any, 
that senescence presents on the susceptibility to radiation at the older end of the age 
spectrum.  
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 When the frequencies of induced aberrations in the irradiated samples (1 – 4 Gy) 
were evaluated within each dose group, we observed age-related increases at 1, 2, and 
3 Gy. At 4 Gy the slopes of the regression lines were generally in the same direction as 
the slopes from the lower doses, although statistical significance was not achieved. 
Rings were the only chromosome aberration type to show statistically significant 
changes with age at 4 Gy. The cells encountered the most damage at this dose and 
probably experienced negative selection during the 48 hr culture period, either dying or 
undergoing cell cycle delay which prevented them from being able to enter metaphase 
where they could be analyzed. In future studies regarding this question, doses of 0, 1, 2 
and 3 Gy may be sufficient.  
 The dose response curves we generated showed statistically significant 
differences between newborns and adults in the frequencies of translocated 
chromosomes, dicentrics, rings, and color junctions. Translocated chromosomes are the 
most stable of all aberrations and for this reason have much greater persistence 
through cell division than dicentrics and rings. Translocated chromosomes are the best 
cytogenetic biomarker for detecting cellular responses to radiation when differences in 
cell growth rates may exist between samples, e.g., between peripheral blood from 
adults and cord blood from newborns. We observed increased frequencies of 
translocated chromosomes in newborns compared to adults confirming our conclusions 
of increased susceptibility of newborns to radiation. More dicentrics were seen in cells 
from adults than from newborns because the two types of donor cell populations differ in 
their growth rates. Newborn peripheral blood lymphocytes have a significantly higher 
mitotic index than adult peripheral blood lymphocytes, which indicates they are dividing 
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faster. Therefore cells with dicentrics are lost more quickly in newborns. The faster 
growing cells undergo stronger negative selection due to the unstable nature of dicentric 
chromosomes, leaving fewer total dicentrics in newborn samples. Rings are also 
unstable aberrations. We observed fewer rings in newborns than adults, which is 
consistent with the data for dicentrics. Color junctions include data from several 
aberration types, and since newborns are more susceptible to radiation they show 
slightly elevated levels over adults because of the increased total damage in their cells. 
Phenotypic and physiological differences are known to exist between adult and 
umbilical cord blood samples. Cord blood contains hemopoietic stem cells that have a 
much higher proliferation rate than adult stem cells in peripheral blood (Holmes et al., 
2009). Cord blood also has almost three times as many total lymphocytes as adult 
blood (Beck and Lam-Po-Tang, 1994) but the lymphocytes are immunologically 
immature and vary in their immunophenotypes analyzed with cell surface markers 
(Lopez et al., 2009). Our observations are consistent with this evidence in that in our 
cord blood samples exhibited an increased concentration of cells in culture and greater 
numbers of cells in metaphase than the adult blood samples; our data for unirradiated 
controls show that the mitotic indices in the older donors were substantially lower than 
in the cord bloods.  
One of the two major findings of this work, the increased susceptibility of 
newborns to radiation, is summarized in Figure 4.17. At the lowest dose used in this 
study (1Gy), newborns showed a 38% increase in the average frequency of induced 
chromosome aberrations. This number declines with dose and the susceptibility 
difference is not discernible at the highest dose of 4 Gy. Most radiation exposures are 
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due to environmental and medical procedures that involve doses well below 1 Gy. We 
cannot extrapolate the graph or speculate on the susceptibility effect at doses below 1 
Gy, but it would be the next logical step in the future of this work.  
Mean telomere length in hemopoietic and mature immune cells decreases with 
age and differs in fetal and newborn samples. Newborns have greater telomere loss 
compared to fetuses (Holmes et al., 2009). Comparing such changes in fetal and 
newborn lymphocytes for their susceptibility to ionizing radiation would be interesting, 
although obtaining viable human fetal tissue is ethically problematic. Future directions 
for this work could include children and young adults aged 0 to 21 years to determine 
how and when the change in radiation susceptibility declines after birth. A parallel 
approach would be to use an animal model such as rats where blood samples from all 
stages of life, including the fetus, could be obtained.  
The work presented here describes the increased cytogenetic susceptibility of 
newborns to ionizing radiation compared to adults. The increase in structural 
chromosome aberrations after radiation exposure at a young age could contribute to the 
known increase in cancer risks associated with childhood exposure. Since susceptibility 
does not appear to change with age once adulthood is reached, radiation risk 
assessments on adults do not need to take age into consideration. Further work is 
necessary to understand better the magnitude and developmental time frame of this 
susceptibility effect in children. 
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APPENDIX A 
PERSONAL QUESTIONNAIRE 
Please read the following questions carefully and answer them as thoroughly and 
accurately as possible. The information you give will not be associated with your name in 
any public document and will be known only to the principal investigators in charge of 
this study. The answers you provide may have a direct bearing on the interpretation of 
the results of this study. Therefore, we ask that you kindly cooperate fully by providing 
correct information. 
Thank you very much for your cooperation in furthering the cause of biomedical 
research. 
1. Name:
 _____________________________________________________________ 
   Last (family)  First (given)   Middle initial 
 Home phone number: ______________ Cell phone number:______________ 
 Home Address: _________________________________________________ 
     Street   apt. number 
    _________________________________________________ 
     City   State / Province ZIP code 
2. To be filled in by principal investigator: 
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  Code Number: _____________________ 
  Date:   _____________________ 
If additional space is needed for the completion of an answer, please write on the back 
of the page and identify the remaining part of the answer with the question's number. 
 
GENERAL INFORMATION 
3. Today's Date: __________________________________ 
    Month  Day  Year 
4. a) What is your age? _______________ (in years) 
 b) What is your birth date? _______________________________ 
     Month  Day  Year 
5. Specify your sex (circle one):  Male  Female 
6. How would you describe your ethnicity?  
 ________________________________________________________________ 
7. What is (was) your most recent occupation?
 ________________________________ 
 _________________________________________________________________ 
8. What other occupations have you had in the last 20 years? 
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 _________________________________________________________________ 
 _________________________________________________________________ 
 
MEDICAL HISTORY 
9. Have you taken any medication prescribed by a doctor in the past one year (for 
example, blood pressure pills, antibiotics, insulin, tranquilizers, muscle relaxants, 
etc.)? 
 ____ YES ____ NO 
 If YES, please indicate: 
Type of Medication Dose How Frequently Per Day? Began (Month) Ended (Month) 
     
     
     
     
     
 
10. Have you ever had a major illness?  ____YES ____ NO 
 If YES, please specify the type of disease(s), when you were ill, and 
indicate the treatment you received. 
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Illness Beginning (month/yr) Ending (month/yr) Treatment Received 
    
    
    
    
 
11. Have you had a blood transfusion in the last one year?   
   ____ YES  ____ NO 
   If YES, when? ____________________________ 
12. Have you had any surgery in the last one year? 
   ____ YES  ____ NO 
   If YES, what kind of surgery? _______________________ 
   When? ____________________________ 
13. Have you ever received a tissue transplant? 
   ____ YES  ____ NO 
   If YES: ______ Organ ______ Bone marrow 
   When? ____________________________ 
14. Have you ever been diagnosed with cancer? 
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   ____ YES  ____ NO 
   If YES, what type of cancer? ______________________ 
   Please indicate the year(s) and describe the treatment you 
received: 
 _________________________________________________________________ 
 _________________________________________________________________ 
 _________________________________________________________________ 
 _________________________________________________________________ 
 _________________________________________________________________ 
15. Have you had any of the following diagnostic or therapeutic procedures in the last 
10 years? 
a) X-rays for: 
i. Broken bones? _____ YES _____ NO 
   If YES, please list: 
# of X-rays Year received 
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ii. Dental? ______YES  _____ NO 
   If YES, please list: 
# of X-rays Year received 
  
  
  
 
iii. Chest? ______ YES  _____ NO 
   If YES, please list: 
# of X-rays Year received 
  
  
  
 
iv. Other? ______YES  _____ NO 
   If YES, please list: 
# of X-rays Year received 
  
  
  
 
115 
 
 
b) Mammograms?  ______YES  _____ NO 
   If YES, please list the years received:  
 _____________________________________________________ 
c) CT scans?  _____ YES  _____ NO 
   If YES, please list: 
# of scans Year received 
  
  
  
  
d) Radiation therapy?  _____ YES  _____ NO 
  If YES, please list: 
# of treatments Duration Year received 
   
   
   
  
e) Chemotherapy?  _____ YES  _____ NO 
  If YES, please list: 
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# of treatments Duration Year received 
   
   
   
 
f) Other diagnostic procedures involving radiation? _____ YES _____ NO 
  If YES, please list: 
Procedure # of times received Year 
   
   
   
 
16. Have you ever been exposed to any other potentially hazardous agents such as 
pesticides, herbicides, insecticides, dyes, solvents, petroleum products, etc.? 
  _____ YES  _____ NO 
  If YES, please describe: 
Type of agent When were you first  
exposed? 
(month/yr) 
When were you last 
exposed? 
(month/yr) 
How long were you 
exposed in total? 
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SMOKING HISTORY 
17. a) Have you ever smoked or used any tobacco products? ____ YES ____ NO 
  If NO: Proceed to question #18. 
  If YES: How long did you smoke? ________ in years 
 b) Do you smoke or use any tobacco products now? ____ YES ____ NO 
  If YES proceed to 17c. 
  If NO: When did you stop smoking, or stop using tobacco products?  
  _____________________________ 
   month  year 
  Proceed to 17h. 
 c) Do you currently smoke cigarettes? ____ YES ____ NO 
  If YES:  How many packs do you smoke each day? ______________ 
 d) Do you currently smoke cigars? ____ YES ____ NO 
  If YES:  How many cigars do you smoke each day?  ________ 
 e) Do you currently smoke a pipe (including hookah)? ____ YES ____ NO 
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   If YES, how many pipes do you smoke each day?_________ 
 f) Do you currently chew tobacco?  ____ YES ____ NO 
   If YES, how many times per day do you chew? _________ 
 g) Do you currently use snuff?  ____ YES ____ NO 
   If YES, how many times per day do you use it? _______ 
 h) If you do not smoke now, what did you smoke in the past? 
   _____ cigarettes   How many per day?  ___________________ 
  _____ cigars  How many per day?  ___________________ 
  _____ pipes (including hookah) How many per day?________________ 
 
ALCOHOL CONSUMPTION HISTORY 
18. a) Do you drink beer?   ____ YES ____ NO 
  If yes, please indicate your average weekly beer consumption:  
  ______ cans/bottles per week 
 b) Do you drink wine?   ____ YES ____ NO 
  If yes, please indicate your average weekly wine consumption:  
  ____  glasses per week.  
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19. Do you drink liquors other than beer and wine? 
  ____ YES ____ NO 
  If yes, please indicate your average weekly consumption for  
  other liquors.  
  ____  shots per week 
 
THANK YOU VERY MUCH FOR YOUR PARTICIPATION IN THIS STUDY! 
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Chapters 2 and 3: 
Depleted Uranium (DU) is a high-density heavy metal that has been used in 
munitions since the 1991 Gulf War. DU is weakly radioactive and chemically toxic and 
long term exposure may cause adverse health effects. This study evaluates genotoxic 
effects of DU exposure in Gulf War I Veterans as a function of uranium (U) body burden 
by measuring chromosome damage in peripheral blood lymphocytes with the 
cytokinesis blocked micronucleus assay (CBMN) and fluorescence in situ hybridization 
(FISH) whole chromosome painting. Study subjects are Gulf War I Veterans exposed to 
DU during friendly fire incidents in 1991 involving DU munitions which resulted in 
inhalation and ingestion exposure to small particles of DU and soft tissue DU fragments 
from traumatic injuries. The Veterans are enrolled in a long term health surveillance 
program at the Baltimore VA Medical Center.  
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Evaluation of subjects using the CBMN assay: 
Blood was drawn from 35 exposed male Veterans aged 36 to 59 years, then 
cultured and evaluated for micronuclei (MN). The participants were divided into two 
exposure groups, low and high, based on their mean urine Uranium concentrations. 
Poisson regression analyses with mean urine U concentrations, current smoking, X-rays 
in the past year and donor age as dependent variables revealed no significant 
relationships with MN frequencies. Our results indicate that ongoing systemic exposure 
to DU in Gulf War I Veterans with embedded DU fragments does not induce significant 
increases in MN in peripheral blood lymphocytes compared to MN frequencies in 
Veterans with normal urine Uranium levels.  
Evaluation of subjects using FISH whole chromosome painting assay: 
Blood was drawn from 35 exposed male Veterans aged 39 to 62 years, then 
cultured and harvested for metaphase chromosome analyses. Chromosomes 1, 2, and 
4 were painted red and chromosomes 3, 5, and 6 were simultaneously labeled green. At 
least 1800 metaphase cells per subject were scored. Univariate regression analyses 
were performed to evaluate the effects of log(urine Uranium), age at time of blood draw, 
log(lifetime X-rays), pack-years smoked and alcohol use against frequencies of cells 
with translocated chromosomes, dicentrics, acentric fragments, color junctions and 
abnormal cells. No significant relationships were observed between any cytogenetic 
endpoint and log(urine Uranium) levels, smoking, or log(lifetime X-rays). Age at the time 
of blood draw showed significant relationships with all endpoints except for cells with 
acentric fragments. These results indicate that chronic exposure to DU does not induce 
significant levels of chromosome damage in these Veterans. 
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Chapter 4: 
To determine the extent to which age influences individual susceptibility to 
ionizing radiation, blood samples were collected from 20 adults and from the umbilical 
cords of 10 newborns. Samples were acutely exposed to Cobalt 60 gamma rays to 
doses of 0 (control), 1, 2, 3 and 4 Gy. Cells in metaphase were labeled with whole 
chromosome paints and evaluated for structural chromosome aberrations. Regression 
analyses were used to evaluate the frequencies of each of the major classes of 
structural aberrations to determine whether susceptibility to radiation was dependent 
upon age. Compared to adults, blood from newborns showed statistically significant 
increases in translocated chromosomes, dicentrics, and color junctions for doses from 0 
to 3 Gy, but not at 4 Gy. When adults were considered alone, no significant changes in 
radiation susceptibility were observed with age. The increased susceptibility of 
newborns to ionizing radiation, and the absence of any change in susceptibility during 
adulthood, should be relevant when making radiation-exposure risk assessments. 
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